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The purpose of the current study is to understand emotional and neurocognitive
functioning in childhood cancer survivors.
In this single-evaluation cross sectional study, 41 childhood cancer survivors (53.2% of
those eligible) in the Health Education Research Outcomes in Survivors (HEROS) Clinic
at Yale-New Haven Hospital between the ages of six and eighteen and their parents and
teachers completed the Behavior Assessment System for Children, Second Edition
(BASC-II), Behavior Rating Inventory of Executive Functioning (BRIEF) and Pediatric
Quality of Life Inventory (PedsQL). Patient’s, parents’ and teachers’ scores were
compared to those of normative populations for emotional, neurocognitive and quality of
life measures. Frequencies of impairment and within population differences in the study
sample were calculated. Responses by patients were compared to those of parents and
teachers to determine inter-rater reliability. The patterns of co-existing neurocognitive
and emotional difficulties in the sample were described. Lastly, elements of emotional
functioning, neurocognitive impairment, and patient characteristics predictive of impaired
quality of life were identified with unadjusted and multivariate analyses.
Overall, 56.1% patients were female, the mean age at diagnosis was 3.6 years, and the
mean age at study completion was 12.8 years. In examining inter-rater reliability, for
most areas of emotional functioning there was poor agreement (kappa < 0.40). Parents
and teachers showed moderate agreement in reporting problems with attention (kappa =
0.57), memory (kappa = .61), and metacognition (kappa = 0.52). Parents and children
showed greater inter-rater reliability when reporting quality of life than symptoms, with
agreement in every realm of the PedsQL (kappa > 0.40). Co-morbidities between
emotional and neurocognitive impairments for the most part did not occur together.
However, impairments in somatization and withdrawal tended to co-exist with
impairments in memory, shift and metacognition (p < 0.05). In the multivariate analyses
looking at social, emotional and school functioning, only neurocognitive functioning was
a consistent predictor of poor quality of life (OR = 12.94, p = 0.008; OR = 11.48, p =
0.044; OR = 33.5, p = 0.003, respectively). Poor emotional functioning was also
predicted by female gender (OR = 15.58, p = 0.025).
Similar to previous studies, a significant proportion of childhood cancer survivors in our
sample endorse difficulties with internalizing symptoms and executive functions, as well
as lower physical, emotional and social functioning, than normative populations. The
current study shows inter-observer variability, especially among indexes of emotional
symptoms, indicating a need for multiple reporters to determine areas of deficit and true
levels of functioning. Problems with memory, shift, initiation and coordination of
problem-solving behaviors co-exist with symptoms of somatization and social
withdrawal in our study. However, it is the neurocognitive rather than emotional
symptoms that are shown to be key predictors of how child-age survivors perceive their
quality of life after therapy. These results highlight neurocognitive impairments as a
target for intervention during and after treatment for pediatric cancers.
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Introduction
Great strides in treatment of childhood cancer have resulted in dramatic
improvements in overall survival rates. With the advent of effective therapies, childhood
cancer has been transformed from an almost fatal disease to one associated with survival
rates of almost 80% in patients who are at least five years post-treatment (1, 2). While
the rates of survivorship are encouraging, there is now a growing need to determine late
outcomes in survivors, most of whom received toxic therapies in order to cure their
malignancies. Depending on the specific treatments they received, survivors are at
increased risk for multiple complications later in life, including subsequent malignancies,
early mortality, growth delay, obesity, pulmonary and cardiovascular disease, and
infertility (3, 4).
Studies have shown that, while the majority of survivors do not experience
difficulties later in life, a small but significant subset are at increased risk for problems
related to neurocognitive and psychosocial impairment, including emotional and social
adjustment (5, 6). Lower socioeconomic status, less educational attainment, and female
gender have been identified as potential risk factors (7, 8). Patients diagnosed during
adolescence may also be particularly vulnerable to psychosocial distress and difficulties
with adjustment (9). Neurocognitive and psychosocial difficulties experienced by
survivors can have a significant impact on their quality of life, which includes and is
defined by social and emotional global functioning (2).
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Emotional and Social Functioning in Childhood Cancer Survivors
Based on the improvements in treatment for childhood cancer, survivorship no
longer refers only to cure rates, but also encompasses the ability of patients to maintain a
good quality of life after treatment. Emotional functioning is a crucial component of
quality of life in survivors, and is defined by an individual’s ability to regulate his or her
feelings and thoughts, including his or her fears, sadness, anger or worries (5, 6, 10).
Social functioning is also a key part of quality of life, and encompasses development of
good and satisfying relationships with peers and feelings of competence in these
interactions. Difficulty controlling one’s emotional and social functioning may lead to an
increase in internalizing symptoms and maladaptive behaviors.
Internalizing Symptoms
Internalizing symptoms include depression, anxiety, withdrawal and somatization.
Depression is described as a disorder characterized by feelings of sadness, inactivity,
crying, physical complaints and changes in behaviors that persist over time, affecting an
individual’s life (11, 12). Anxiety includes feelings of apprehension or fear that can
include physical sequelae (13, 14). Withdrawal refers to detachment from social
situations, while somatization is described as experiencing over-sensitization to relatively
minor physical injuries or complaints (7, 13). Several chemotherapeutic agents have
been associated with altered behavior, anxiety, and depression in different disease
populations, and greater treatment intensity has been shown to play a role in development
of these symptoms in previous studies (8, 15).
Overall adult and pediatric survivors experience clinically significant levels of
depression and anxiety estimated at two- to three-times that of the general population
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during and after treatment combined (16). While studies of quality of life and
psychosocial functioning report that the majority do well, a small but significant group of
survivors have been shown to experience anxiety, depression and low self-esteem many
years after treatment (1). In the Childhood Cancer Survivor Cohort, Zebrack et al.
evaluated 11,000 patients and showed that 5.4% of patients report symptoms of
depression compared to 3.4% in the sibling comparison group (8). In another study,
parents of 2,979 survivors reported a 1.5-fold increase in depression and anxiety for
survivors compared to a sibling control group (13). Children who have survived
childhood cancer also have been shown to report higher scores on tests that measure
tension and apprehension than age-matched healthy peers (17). Recklitis et al. described
that when screened for psychological distress using the Symptom Checklist-90, 31.7% of
survivors showed impairments (18). These studies indicate the existence of internalizing
symptoms in the population of pediatric cancer survivors, but further understanding of
the reasons for and impact of this distress is necessary.
Social Adjustment
Childhood cancer survivors have also been shown to exhibit impairments in social
functioning and adjustment. Social functioning is the individual’s ability to
communicate, make friends, and match the pace of peers, as well as the character of his
or her peer interactions. Analysis of social functioning includes examining adaptability,
leadership skills, and tendencies toward withdrawal and atypicality (9). Previous studies
have shown that childhood cancer survivors participate in activities less often and spend
more time by themselves than their siblings and age-matched peers (19). Furthermore,
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adolescent survivors have been reported to have a less well-developed sense of identity
(10).
A number of disease and treatment factors have been shown to correlate with
increased difficulty with social functioning. Survivors of brain tumors endorse
impairments in social skills and social adjustment (20). Children who received cranial
radiation or intrathecal chemotherapy, such as methotrexate, have been shown to exhibit
more social and psychological difficulties (14, 21). In a study of long-term adolescent
and young adult survivors, with the majority having had leukemia or lymphoma, older
age at treatment and greater frequency of relapse were also associated with more
impairments in psychosocial functioning (22).
Relationships with peers and family members have also been shown to be affected
in the survivor population. Spirito et al reported that survivors have fewer friends (19),
while Barrera et al. found that survivors were less likely to use friends as confidants than
healthy children (23). Survivors may also be less satisfied with their relationships with
their friends than are their peers, as shown by Gray et al. (24). Family interactions are
influenced by a child having cancer. In one study adolescent survivors reported lower
levels of family cohesion than healthy controls, with nearly 40% labeling their families as
disengaged (25). Perceived family cohesion and social support is strongly related to
overall psychological well-being in all populations (25, 26).
Rates at which survivors achieve independence in adulthood are also altered.
Outcome studies suggest that, compared to normative populations, survivors are more
likely to live with their parents and are less likely to marry (27-31). A large report of
8,900 patients through the Childhood Cancer Survivor Study showed that survivors are
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1.6 times less likely to marry than the general population, and 1.8 times less likely than a
sibling comparison group (32). This lower marriage rate may indicate deficits in social
functioning and interactions with peers.

Neurocognitive and School Functioning in Childhood Cancer Survivors
Fifty to sixty percent of childhood cancer survivors are also at risk for
neurocognitive impairments due to the therapies they received (33). These
neurocognitive late effects include difficulties with attention, concentration, memory,
processing speed, and executive function. Attention and concentration are defined by the
ability to focus on tasks without distraction (15, 34). Memory describes an individual’s
ability to hold on to and recall information (33, 35), and processing speed refers to the
speed and efficacy with which individuals understand and mentally compute information
(33). Executive functions are the processes necessary for organizing and guiding
behaviors during problem-solving, which include planning, insight, organization and
initiation of behaviors (33, 36). Executive functioning is highly correlated with
neurocognitive functioning, as executive functioning is thought to be located in the
prefrontal cortex (36).
Difficulties with neurocognitive functioning are especially pronounced in
survivors of cancers of the brain and central nervous system; outcomes are most impaired
in survivors of brain tumors and acute lymphoblastic leukemia, who generally received
therapies directed at the central nervous system (33, 37, 38). Cranial radiation and
neurotoxic chemotherapeutic agents, including methotrexate, corticosteroids, and
possibly cytarabine hydrochloride, have been associated with neurocognitive late effects
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(15, 33, 37, 39). Younger age at diagnosis and therefore treatment has been associated
with greater impairment in neurocognitive functioning because of the degree of brain
maturation at the time of therapy (33).
These difficulties can play a role in many aspects of daily functioning, ranging
from school performance to social interactions, and therefore it is important to understand
their impact on an individual’s quality of life. Studies have shown a correlation between
neurocognitive exposures and poor decision-making leading to risky behaviors (40).
Neurocognitive and behavioral outcomes are highly interrelated, so neurocognitive
deficits must be considered when examining psychological and social functioning.
Further studies also document reduced school functioning in the population of
childhood cancer survivors (41). This includes the ability to pay attention and remember
information, as well as to regularly attend and keep up with work for school. Evans et al.
revealed that 67% of survivors felt that their education had suffered because of their
cancer (42). Studies have shown that childhood cancer survivors are more likely to
repeat grades (7, 24), and that survivors of central nervous system tumors have lower
school functioning (43). Even when obtaining similar levels of educational attainment as
their healthy peers, survivors have reported feeling at a disadvantage because of their
illness experience and underestimating their abilities, which can negatively affect school
performance (44, 45). School functioning plays a role in the individual’s quality of life,
even outside of the isolated school setting, as children are in part defined by themselves
and by their peers by their performance in the academic environment. In some previous
studies, school functioning has been shown to be the prime determinant of social skills
and psychological adjustment in pediatric survivors (41).
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Social Cognitive Theory
Social and neurocognitive functioning are important to examine in populations of
individuals who have undergone treatments for serious illnesses. However, it is crucial to
not only understand the treatment-related impairments found in this population, but also
to examine how these impairments affect the patients’ self-perceptions of their
performance and quality of life, and this is the goal of the current study. Psychological
ability plays a direct role in determination of an individual’s own efficacy expectation. In
1977, Albert Bandura described efficacy expectation as “the conviction that one can
successfully execute the behavior required to produce the outcomes” (46). He theorized
that development of self-efficacy is affected by the individual’s experiences and the
context of his or her life. Bandura wrote that this expectation ultimately determines how
an individual is able to develop and exhibit coping behavior, and subsequently also drives
selection of behaviors (46).
Wheeler and Ladd, in developing a scale to analyze the interaction between selfefficacy and peer relationships, reinforced this concept. They found that children endorse
higher levels of self-efficacy in non-conflict situation, strengthening the notion that an
individual’s experience shapes his or her self-perceptions (47). This self-assessment of
competence also determines how individuals interact with their peers. Wheeler and Ladd
theorized that a key aspect of social competence is the individual’s skill at appropriately
interacting with their peers, and that a high level of social competence is crucial to the
development of relationships. They found that anxiety and other emotions are associated
with self-perception of competence in social behaviors (47). Harter later added that
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children tend to judge their social popularity based on how they judge their physical
abilities and athletic skills (48). Children analyze their own thoughts, behaviors and
perceptions of their capabilities, thus determining their self-efficacy and ultimately
affecting their social interactions. Negative symptoms endorsed by an individual will
therefore play a large role in the individual’s experiences and quality of life.
Given that self-efficacy is dependent on the individual’s situation and
environment, children’s self-perceptions are influenced not only by the experience of
their illness and treatment, but also by those they interact with the most -- their parents
and guardians. A child’s self-perceptions may be affected by his or her parents’ attitudes
and subsequent treatment. Ladd and Price found in 1986 that parent’s perception of the
difficulty of a situation had a correlation with the child’s ability to perform a measure, but
not necessarily the child’s own self-perception of competence (49). The current study
aims to further investigate this concept by examining the importance of the reporter -looking at how parents and teachers report children are performing and comparing those
results to children’s self-reports of their own quality of life. Understanding these
differences in perception will serve to describe the forces that help drive how survivors of
childhood cancer develop their self-efficacy expectation. Integrating reported levels of
competence and self-perceptions, and therefore the relationships between impairments
and self-perception of quality of life, can help target therapies with a goal of improved
functioning.

A range of studies have revealed the existence of impairments in childhood cancer
survivors and other research has detailed the importance of self-efficacy in the
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development of behaviors. With the identification of the spectrum of late outcomes, it is
crucial to move forward and work to understand the effects of these deficits on selfefficacy and the daily quality of life of survivors. Survivorship no longer only describes
cure, it also entails maximizing life experience after treatment. While it is known that the
late outcomes of childhood cancer treatments are significant enough to influence quality
of life, the ways in which this happens have not yet been characterized. It remains
unclear which groups are most at risk for psychosocial deficits and what is the relative
contribution of these impairments in emotional functioning to global quality of life in
survivors.
Building on the work of other studies that have identified areas of deficit, the
current study simultaneously measures emotional functioning, neurocognitive
functioning, and quality of life in a small sample size to understand how these deficits in
functioning predict qualify of life. Using descriptive data of emotional and
neurocognitive impairments to characterize the study population, the study compares
differences in perception depending on the reporter and analyzes emotional and
neurocognitive deficits to determine co-morbidities. This information is then used to
understand predictors of poor quality of life as perceived by childhood cancer survivors.
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Statement of Purpose and Hypothesis
The overall purpose of the current study is to describe and analyze the emotional
and social functioning of childhood cancer survivors using a sample of patients from the
Yale University Health Education Research Outcomes for Survivors (HEROS) Clinic.
Building on the work of previous studies, patients in the present study undergo
simultaneous measurement of emotional functioning, neurocognitive functioning, and
quality of life to accomplish three primary aims.
First, the study aims to determine if there is inter-rater reliability between
respondents. This goal is accomplished by looking at agreement between results of
parent-, teacher-, and self-reports. The current study hypothesizes that parents and
teachers will report impairments in different areas than those self-reported by survivors.
Second, the study aims to characterize the co-existence of neurocognitive and
emotional domains of impairment. In accomplishing this aim, the study tests the primary
hypothesis that, as shown by these instruments, impairments in internalizing symptoms,
emotional symptoms and executive functioning tend to occur together. It is hypothesized
that the current study will support the results of previous literature in describing
emotional and neurocognitive impairments to characterize the study population. These
results would indicate that childhood cancer survivors endorse higher levels of
internalizing symptoms, show impairments in the social domains of adaptability,
leadership and social skills, and exhibit problems with executive functioning, including
attention and memory.
Third, the study aims to identify factors of impairment in neurocognitive
functioning, emotional functioning, and patient characteristics that predict worse quality
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of life as reported by the survivors themselves. The study hypothesizes that
neurocognitive and emotional impairments will correlate with and predict lower levels of
quality of life functioning as shown by the self-report version of the Pediatric Quality of
Life Inventory. Lastly, it is hypothesized that, because of the unique developmental
challenges of transitioning to independence during adolescence, adolescent age at the
time of testing will predict worse self-perception of quality of life. Determining the
predictors of impaired quality of life in the study population, this research hopes to set the
stage for learning more about possible areas and methods of therapeutic intervention both
during and after treatment.
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Methods
Study Population
Eligibility for participation in this cross-sectional study was limited to patients
enrolled in the Yale University Health Education Research Outcomes for Survivors
(HEROS) Clinic. Attendees of the HEROS clinic must be in remission and at least three
years post-diagnosis of their primary malignancy. Eligibility was restricted to patients
aged six to eighteen years of age who either spoke English of Spanish. These criteria
match the age ranges and languages for which the survey instruments were available. In
addition, the parent or guardian was required to have a written knowledge of English or
Spanish. Children who could not yet read could have the surveys read to them by a
parent, guardian or member of the research team.
Prior to initiation of this study, the co-investigator for this study, Tamara Porter
Miller, completed and submitted an application to the Human Investigations Committee
with the assistance of the principal investigator, Dr. Nina Kadan-Lottick.1 This protocol
was approved on first review.

Participation and Recruitment Procedures
Patient recruitment began on July 19, 2005 and completed when the study closed
on November 30, 2008. Patients and their families were approached about participation
in the present study during their routine annual appointments by the co-investigator or a
member of the HEROS Clinic staff. The co-investigator trained clinic staff to describe
1

The Principal Investigator for the current study was Dr. Nina Kadan-Lottick, M.D., M.S.P.H. The coinvestigator was Tamara Porter Miller. Clinic staff also assisted in the execution of the present study.
These staff members included Beverly Crowther M.Ed., Sheila Santacroce, Ph.D., Jodi Emir, R.N., and
Kim Trotta, R.N. Additional guidance and assistance with data analysis was provided by other members of
the HEROS Clinic Team, including Sui Tsang and Dr. Natasha Buchanan, Ph.D.
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and consent patients for the study prior to study recruitment. If interested, the risks and
benefits of the study were discussed. The parent and child then signed consent and assent
forms respectively, as well as a research authorization form, while in the clinic waiting
room. These consent and research authorization forms were written by the coinvestigator and principal investigator and were approved each year by the Human
Investigations Committee prior to use.
The parent and children were given the survey instruments to complete while
waiting for their appointments. The parents were also given a survey that they were
instructed to give to the most recent teacher who knew their child best. This survey was
attached to a stamped, addressed envelope in which the teacher could return the survey.
Parents and children could decline to include a recent teacher in the study and still
participate in the study. The co-investigator or a trained HEROS clinic staff member was
available at all times during the visit to answer questions about the consent process, risks
and benefits, and survey instruments. The parents and children were given a phone
number to call with questions.
When recruited in clinic the majority of patients did not have enough time to
complete the surveys, and took the packets of questionnaires home to complete and return
in self-addressed, stamped envelopes. Per protocol, as approved by the Human
Investigations Committee, patients were contacted by phone if they had not returned the
questionnaires. Families were asked if they had any questions about the surveys and
were encouraged to send the packets back as soon as possible. If necessary, a second
packet of surveys was sent. In rare cases, the patiens and their parents did not complete
the packets for the entire year between recruitment and their regularly scheduled clinic
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appointment the following year. In these situations, the patients were called prior to the
visit and asked to bring the completed surveys with them, or were re-recruited at the
second clinic visit.
Patients were also recruited by mail, as approved by an amendment to the original
protocol accepted by the Human Investigations Committee. At the end of the first
summer of recruitment, in September, 2005, the co-investigator sent packets to every
current patient in the HEROS Clinic who had not already been recruited in clinic. These
packets included a letter explaining the study, age-appropriate assent and consent forms
for the patients and their parents, the research authorization form, age-appropriate study
instruments, and two addressed, stamped envelopes. Prior to distribution of the packets,
each member of the HEROS Clinic was assigned a Clinic identification number. This
number was written on the survey instruments in place of the patient name in order to
provide anonymity. The envelopes in the package were addressed directly to the
Principal Investigator.
The patients and parents were asked to put the signed consent and assent forms,
the signed research authorization form, and the completed surveys into the large envelope
and to return it as soon as possible. The smaller envelope in the packet was for the
family to give to the most recent teacher who knew the child best. When received at
Yale, the consent and authorization forms were separated in order to ensure future
confidentiality. All further analyses of the data in the surveys were performed based on
HEROS Clinic identification number instead of patient name.
A number was provided in the recruitment letter for patients to call with questions
or to decline participation. If patients had not called to refuse participation, they were
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contacted with two further mailings and, if they came to clinic for their regularly
scheduled appointments, were approached in person. Per protocol approved by the
Human Investigations Committee, patients and their families could also be contacted by
phone after the second mailing if they had not returned the packets or called to decline
participation to determine if they had any questions. It was made clear both in the
mailing letter and during recruitment in clinic that refusal to participate would not affect
the child or family’s relationship with their doctors in the HEROS Clinic.
Despite efforts to follow-up with patients and encourage return of packets, three
families who had consented to participate did not return the surveys before the study
period ended and were categorized as passive refusals. In addition, two families reported
mailing packets that were never received. These families were approached about
repeating the surveys, but declined to do so.

Study Procedures
The self-report surveys took child respondents approximately fifteen to twenty
minutes to complete, and parent and teacher respondents thirty to forty minutes to
complete. Participants were informed that each child would be assigned an identification
number so that their names would not be directly listed on the surveys with their
responses. Once completed, surveys were stored in a locked area separately from the
consent forms to maintain confidentiality.
The patient, parent and identified teacher all completed age-appropriate and
audience-specific versions of the Behavior Assessment System for Children, Second
Edition (BASC-II). The parent and teacher completed parent- and teacher-versions of the
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Behavior Rating Inventory of Executive Function (BRIEF). The parent and child also
completed age-appropriate parent- and child-versions, respectively, of the Pediatric
Quality of Life Inventory, Version 4.0 (PedsQL). The parent answered an intake
questionnaire, the Family and Social History Questionnaire, collecting information about
family, social, school, pre-treatment, birth and cancer treatment history.
Patients enrolled in the HEROS clinic were asked a variety of demographic,
family and social history, and treatment-history related questions during their initial visit.
This information, combined with information in the patient’s medical record related to
their diagnosis and treatment history, was compiled in the HEROS Clinic database.
Information in this database was collected for the patients enrolled in the present study
and used to stratify and characterize patients during the analysis. This data included
information about the primary diagnosis, subsequent malignancies, chemotherapy and
radiation history, and complications and outcome history.

Study Measures
Behavior Assessment Scale for Children, Second Edition (BASC-II)
The BASC-II (Reynolds, CR and Kamphaus, RW, 2004) is a set of surveys that
examines adaptive and maladaptive behaviors, thoughts and emotions of children and
adolescents (50). The BASC-II is often used to examine affective and mood disorders in
children as perceived from the parent’s and teacher’s point of view or as self-reported
from the child.
Self-, teacher- and parent-report versions of the BASC-II were used in the age
categories between ages six and eighteen years. The SRP-C, a self report for ages eight
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through eleven, has 139 items. The SRP-A, a self report for age twelve through twentyone, has 176 items. The PRS-C, or parent rating scale for ages six through eleven, has
160 items. The PRS-A, completed by parents for their children aged twelve to twentyone has 150 questions. The teacher versions, the TRS-C for ages six to eleven and the
TRS-A for ages twelve to twenty-one, each have 139 items. The parent, teacher or child
completing the survey is asked to read each statement and mark the response that best
describes how the child has acted over the previous six months (never, sometimes, often,
or always). The self-report version also requires the child to respond to a series of true or
false questions.
On the parent and teacher versions, the scales are divided as described below.
The first scale, Externalizing Problems, includes Aggression, Hyperactivity and Conduct
Problems. The second scale, Internalizing Problems, includes Anxiety, Depression, and
Somatization. The next scale, School Problems, includes Attention Problems and
Learning Problems. The Adaptive Scale includes Adaptability, Leadership, Social Skills
and Study Skills. There is also an Atypicality scale that is used with Withdrawal and
Social Skills to gauge unusual behaviors and impaired relations. Lastly, there is a broad
scale called the Behavioral Symptoms Index; this includes Hyperactivity, Aggression,
Depression, Attention Problems, Atypicality, and Withdrawal. There is also a subscale
called Activities of Daily Living, which analyzes the individual’s skills at completing
routine daily tasks, and a subscale called Functional Communication, which evaluates the
ability to effectively communicate thoughts and ideas (50) (for definitions of each scale,
see Table 1).
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Table 1 - Definitions of Scales on the Behavior Assessment Scale for Children,
Second Edition (50)
Scale
Externalizing Problems
Aggression
Hyperactivity
Conduct Problems

Definition
Behaviors of physical or emotional harm towards others
Impulsive and excessively active tendencies
Disruptive behaviors in school or at home

Internalizing Problems
Anxiety

Feelings of apprehension or fear that can include physical sequelae (13, 14)

Depression

Feelings of sadness, inactivity, crying, or changes in behavior (11, 12)

Somatization

Over-sensitization to relatively minor physical injuries or complaints (7, 13)

Atypicality
Locus of Control

Behaviors that are unusual for the child’s age

Social Stress

Tension and anxiety felt by children in social situations, only on self-report

Sense of Inadequacy

Self-perceptions of ability, only on the self-report

Control over external situations, only on self-report

School Problems
Attention Problems
Learning Problems

Difficulties with maintaining focus and ease of distractibility
Deficits in understanding academic problems and obtaining high levels of
academic achievement

Adaptive Skills Composite
Adaptability

The ability to change and to positively react to change

Social Skills

Interactions with others

Leadership

Tendencies to take charge when working with others

Study Skills

Abilities in an academic setting

Personal Adjustment
Relations with Parents

Interactions with parents, only on self-report

Interpersonal Relations

Interactions with peers, only on self-report

Self esteem

The child’s happiness with his or her self, only on self-report

Self-Reliance

Self-perception of decision making capability, only on self-report

Withdrawal

Behaviors of social avoidance and being reclusive

Activities of Daily Living

The individual’s skills at completing routine daily tasks

Functional Communication
Behavioral Symptoms
Index

The ability to effectively communicate thoughts and ideas

On the self-report the first scale is School Problems, and includes Attitude to
School, Attitude to Teachers and Sensation Seeking. The Internalizing Symptoms scale
includes Atypicality, Locus of Control, Social Stress, Anxiety, Depression, Sense of
Inadequacy and Somatization. The Inatttention/Hyperactivity scale includes Attention
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Problems and Hyperactivity. The Emotional Symptoms Index is a broad scale that
includes Social Stress, Anxiety, Depression, Sense of Inadequacy, Self-Esteem and SelfReliance. Lastly, the Personal Adjustment scale includes Relations with Parents,
Interpersonal Relations, Self-Esteem and Self-Reliance (50) (for definitions of each scale,
see Table 1).
Answers to the survey questions are inputted into a computer program that
calculates the scaled scores for each index. Scores were compared to the general,
combined sex normative population. The Adaptive Scales include Functional
Communication, Adaptability, Activities of Daily Living, Leadership, Social Skills and
Study Skills; the other scales are considered Clinical Scales. In scoring the surveys, Tscores on the Adaptive Scales are considered at-risk below forty and clinically significant
at thirty and below. For the Clinical Scales T-scores are considered at-risk when greater
than sixty and clinically significant when greater than seventy (50).
The BASC-II has been used in a variety of populations to analyze emotional and
behavioral problems in children. These groups have included healthy children, children
with a range of illnesses, and children from a variety of socioeconomic and ethnic
backgrounds. The instrument has been compared to other assessment surveys and been
shown to be a valid and useful tool for maladaptive behaviors. Reliability was studied by
the authors. Reliability scores for the teacher version ranged from 0.85 to 0.95, with
composite scores having the highest reliability. Reliability scores are reported by the
authors to range from 0.83 to 0.87 for the parent version and the mid-0.70s to the mid0.80s for the self-report version (51).
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Behavior Rating Inventory of Executive Function (BRIEF)
The BRIEF (Gioia, GA, Isquith, PK, Guy, SC, Kenworthy, L, 2000) is a parentand teacher-completed instrument that assesses the child’s emotional control, ability to
inhibit and short attention, initiation, working memory, planning, and organization of
materials (36). There is one parent version and one teacher version; the scaled score
adjusts for the age of the individual. It is an 86-item questionnaire divided into eight
clinical scales and two validity scales. These are grouped into two broader indexes of
Behavioral Regulation and Metacognition. The parent or teacher is asked to read each
statement and answer how much of a problem the child has had with each statement in
the previous six months (never, sometimes, often).
The results are tallied and the raw scores are converted to scaled, or T-scores.
The results are divided into the following scales: the Behavioral Regulation Index (BRI)
and the Metacognition Index (MI). The BRI includes the subscales of Inhibit, Shift, and
Emotional Control, and describes the individual’s ability to appropriately control and
modulate emotions and behaviors. The MI includes the subscales of Initiate, Working
Memory, Plan/Organize, Organization of Materials, Monitor. The MI reveals the child’s
ability to start, arrange and coordinate problem solving in working memory. All of the
subscales are combined into one summary scale, the Global Executive Composite (GEC)
(36) (for definitions of each scale, see Table 2).
The T-scores are compared to a standardization sample to determine if the results
are clinically significant. Higher T-scores indicate more problems with executive
function. In evaluation of results from both the teacher and parent versions of the
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Table 2 - Definitions of Scales on the Behavior Rating Inventory of Executive
Functioning (36)
Scale
Behavioral Regulation Index
Inhibit
Shift
Emotional Control
Metacognition Index
Initiate
Working Memory
Plan/Organize
Organization of Materials
Monitor
Global Executive Composite

Definition
The ability to appropriately control and modulate emotions and
behaviors
The ability to control impulses and stop behavior
Aptitude in moving freely between activities and problem-solving
flexibility
Emotional regulation and expression of executive functioning
The ability to start, arrange and coordinate problem solving in working
memory
The ability to begin activities and generate ideas
The ability to retain and recall information during problem solving
The ability to coordinate tasks
The tidiness of a child’s work and play areas
The tendency to check work and assess one's own performance
Summary analysis of executive functioning

BRIEF, T-scores equal to or greater than 65 are considered at risk for clinical
significance on all scales (36).
The BRIEF was normalized with a set of 1419 parent forms and 720 teacher
forms. The sample represented both genders and a broad socioeconomic and ethnicallydiverse group (52). The reliability and validity for the BRIEF were studied and are
reported in the manual for the study instrument. Content and construct validity were
studied by the authors and a group of neuro-psychologists. The reliability scores, which
measure internal consistency, ranged from 0.80 to 0.98 for both the parent and teacher
versions of the BRIEF (36, 52).

Pediatric Quality of Life Inventory, Version 4.0 (PedsQL)
The PedsQL (Varni, JW, 1998) is a global quality of life survey that assesses
children’s emotional and social status. It is intended to be given to both healthy

22
populations and children with acute and chronic diseases. It is intended to distinguish
between these populations and determine disease severity within the group of children
with chronic illnesses. The instrument includes parent and child versions for each age
group. The current study used the surveys targeted for the ages 5-7, 8-12, and 13-18.
The PedsQL is a twenty-three-item survey divided into four sections: physical
functioning, emotional functioning, social functioning, and school functioning. There are
eight questions about physical functioning, and five questions in each of the other three
categories.
The parent or child is asked to read each statement on the questionnaire and mark
the response that best describes how much of a problem the statement has been in the
previous month (never, almost never, sometimes, often, almost always). The answers are
converted to numerical z-scores. They are tabulated to give a Total Scale Score, a
Physical Health Summary Score (eight items), and a Psychosocial Health Summary Score
(fifteen items). Higher z-scores correlate with better quality of life. Lower z-scores
indicate reports of worse quality of life. In the current study physical functioning data
was obtained but not used for further analysis, as this was out of the scope of this
research.
The author of the PedsQL studied the reliability and validity of the instrument in a
population of 963 children and 1629 parents. Varni et al. found that there was internal
consistency reliability for the Total Scale Score of 0.88 for the child surveys and 0.90 for
the parent surveys. Validity was proven through positive correlations with indicators of
mortality and illness burden and through ability to distinguish between healthy and sick
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children (53). The PedsQL was analyzed in an ethnically diverse and socio-economically
heterogeneous populations of healthy and sick children (53).

Family and Social History Questionnaire
The Family and Social History Questionnaire is an intake survey written by the
co-investigator and principal investigator and completed by the parent. The survey aims
to collect demographic data and information about the child’s school and treatment
history. It was used to stratify results from the other surveys by patient characteristics.
This data was used with the information from the HEROS database to understand the
type of cancer and therapy each child received, as well as the child’s daily living
situation. Data collected included: Race, Living Situation (Parents divorced/married,
Siblings, Who Lives at home, Who is the primary caregiver), Present age, Current grade,
If the child attended school during therapy, What type of school the child attends, If and
what type of special education services the child receives, Medication history and current
medications (Anti-depressants, Ritalin, etc.), and History of mental health services
(Psychotherapy, Behavioral Therapy, Psychotropic drugs).

Data Analysis
The pattern of impairment in the study population was described in order to
characterize the population and to be used for further analyses. This was accomplished
by comparing the data from the BASC-II, BRIEF and PedsQL to the scores of published
age- and gender-specific normative populations. Two-sided one sample student T tests
were then conducted to compare observed frequency of impairment in the research
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population with the expected proportions in the general population. Outcomes were
examined as mean scores as well as percentages of the population in the impaired range.
Percentages of impairment were compared using Fisher’s test to evaluate for significant
differences between groups. P-values less than 0.05 were considered statistically
significant.
In order to further describe the emotional, neurocognitive and quality of life
functioning in the study population, children were divided by gender and by age at
diagnosis of less than 3.5 years of age or greater than or equal to 3.5 years of age. Age at
diagnosis was analyzed because previous literature has shown that younger age at
diagnosis impacts symptoms of late effects, especially in neurocognitive functioning.
The age cutoff was chosen because, in the current study population, the mean was 3.6
years and the median was 3.4 years.
Patients were also analyzed by age at study completion because prior studies
indicate different presentation of late effects in adolescents and younger populations.
Adolescent age was considered from twelve to eighteen years of age and pre-adolescent
age was six through eleven years of age. This was determined using the age breakdowns
of “Child” and “Adolescent” on the BASC-II. Patients were also divided based on their
receipt of central nervous system-directed therapies, which included intrathecal
chemotherapy and cranial irradiation.
To accomplish the first aim of the study -- to describe inter-rater reliability -kappa statistics analyzed agreement of perceptions reported on the parent, teacher and
self-report versions of the survey instruments. Inter-rater reliability for a given scale was
evaluated to produce kappa coefficients, which are measures of agreement. Kappa
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coefficients of 0.41 to 0.60 were considered moderate strength of agreement, and values
of 0.61 to 0.80 were considered substantial strength of agreement. A kappa value
between 0.81 and 1.00 was considered almost perfect strength of agreement (54). Pvalues were used to determine if the agreement was due to chance.
Specifically, the attention scales on the parent and teacher versions of the BASCII were analyzed. Parent and self-report versions of the BASC-II were evaluated for
agreement on the scales of depression, anxiety, withdrawal, somatization, attention and
internalizing problems. Inter-observer reliability between parent and teacher perceptions
of executive functioning were analyzed with reports on the BRIEF of memory, inhibition,
shift, planning and organization, initiation, monitor, the Metacognition Index (MI) and
Global Executive Cognition (GEC). Parent and child perceptions of quality of life were
analyzed for agreement using the parent and self-report versions of the PedsQL on the
school, emotional and social functioning scales. The physical functioning scale was not
examined because it was out of the scope of this study. There is no teacher-report
version of the PedsQL. To understand different perceptions of school functioning
between teachers and children, self-report of school functioning on the PedsQL was
evaluated for agreement with teacher-report on the BRIEF of problems with memory,
planning, initiation, and organization of materials.
The second aim of the current study is to characterize co-morbidities between
neurocognitive and emotional problems. To accomplish this goal, two-by-two
comparison analyses were created evaluating specific scales on different survey
instruments. Among the group of parents reporting impairment in an emotional outcome,
the percentage of parents reporting co-existing impairment in a given neurocognitive
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outcome was assessed. Fisher’s tests were run to determine the presence of a significant
association with p-values less than 0.5 showing statistically significant association. Chisquare analysis could not be performed due to the small sample size of the study.
Using the descriptive data of emotional and neurocognitive functioning in the
study population from the study instruments, anxiety and depression, somatization,
withdrawal and internalizing symptoms on the parent-report BASC-II were each
compared in two-by-two tables to the memory, organization of materials, initiation, shift,
monitor, inhibition and metacognition index scales on the parent version of the BRIEF.
To determine these co-morbidities, the parent versions of the BASC-II and BRIEF were
used. The parent versions were utilized due to the parent’s ability to examine the child in
several environments. This was chosen based on previous literature using parent-report
to analyze behaviors in childhood cancer survivors (2, 19). While parent-report cannot
provide a sole substitute for child-report, it has been shown to be a useful and valid
measure (55). For consistency, the parent versions were used in all further analyses
examining endorsement of symptoms. Self-report could not used because the BRIEF, the
most reliable and valid measure of problems with neurocognition used in this study, does
not include a self-report version.
The study’s third aim is to identify factors that predict poor quality of life
functioning. To accomplish this aim an unadjusted and adjusted multivariate analysis
was performed. The parent- report versions of the BASC-II and BRIEF were used for
these analyses. However, the self-report version of the PedsQL, the quality of life
inventory, was selected to obtain the best understanding of the effects of impairments on
childhood cancer survivors.
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The demographic predictors of female gender and adolescent age were selected to
be analyzed as predictors of poor quality of life. These were selected based on reports in
the literature and the results of the current study showing greater impairments in these
populations. Age at diagnosis and age at study completion were shown by this and
previous studies to be correlated, and age at testing is considered a better determinant of
functioning, so it was chosen for the multivariate analysis. Additionally, in order to test
the hypothesis that endorsement of internalizing symptoms and problems with executive
functioning predict lower quality of life, parent rating of impairment on the internalizing
symptoms scale on the BASC-II and parent rating of impairment on the metacognition
index of the BRIEF were used in the linear regression. The internalizing symptoms scale
on the BASC-II was selected as a strong measure of emotional functioning, and the
metacognition index on the BRIEF was chosen as a good overall measure of
neurocognitive function. These demographic and symptom predictors were used to
analyze the scales of school functioning, emotional functioning and social functioning on
the self-report PedsQL via an unadjusted and adjusted linear regression.
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Results
Characteristics of the Study Sample
Forty-one of the seventy-seven (53.2%) patients contacted consented to
participate in the current study. A combined twenty-seven (35.1%) patients actively or
passively refused participation. Three patients out of the seventy-seven contacted (3.9%)
were recruited and consented to participate, but never returned the study instruments.
Two (2.6%) of the contacted patients consented to participate and reported putting the
completed surveys in the mail, but these surveys were never received. These patients
were approached about re-completing the surveys but declined to do so; these packets are
considered lost in the mail. Four (5.2%) recruited patients were deemed to be ineligible
(see Figure 1). Of these recruited, ten (24.4%) were recruited by mail and twenty-four
(58.5%) were recruited in clinic. Seven (17.1%) of those recruited were contacted by
mail and did not respond, but were later recruited in clinic (see Figure 1).
Of the twenty-seven who refused participation, seven (25.9%) actively refused
participation in the study in clinic. Fourteen (51.9% of refusals) patients who were sent
packets never responded nor came to clinic, and are considered passive refusals. Six
patients (22.2% of refusals) who were mailed surveys did not respond or have clinic
appointments before they turned nineteen, which was too old for the study; these patients
aged-out and are also considered passive refusals (see Figure 1).
The mean age at diagnosis in the study population was 3.63 years, with a standard
deviation of 2.55 and a range of zero to 12.66 years (see Table 3). The median was 3.37
years. The age at diagnosis was skewed to the left, with 23 patients (56.1%) diagnosed
before age 3.5, and 18 (43.9%) diagnosed at age 3.5 or older.
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Figure 1 - Diagram Showing Success of Study Recruitment and Reasons for Refusal
of Participation
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The mean age at testing, defined as the time of study completion by the parent,
child and teacher, was 12.85, with a standard deviation of 3.54 and a range of 6.67 to
18.98 years. Patients were considered too old for the current study once they turned
nineteen. Sixteen (39%) of patients were pre-adolescent, defined as ages six through
eleven, and 25 (61%) were adolescents, aged twelve through eighteen (see Table 3). The
variation in age at testing was great, with the most numbers of patients aged nine, twelve
and fourteen, with five patients each. The mean age since completion of cancer treatment
was 9.21 years, with a standard deviation of 3.53 and a range of 4.16 to 16.37 years.
The largest group of patients was white; thirty-two (78.1%) of the patients studied
were Caucasian and non-Hispanic. Five (12.2%) were Hispanic and two (4.9%) were

30
Table 3 – Comparison of Participants and Non-Participants in Terms of
Demographics and Treatment Factors A
Participants
N (%)

Non-Participants
N (%)

pvalue

Gender
Female
23 (56.1%)
12 (44.4%)
0.458
Male
18 (43.9%)
15 (55.6%)
Ethnicity
White
36 (87.8%)
16 (88.9%)
0.831
Non-WhiteB
4 (9.8%)
2 (11.1%)
Unknown
1 (2.4%)
Household Income
< $40,000
3 (7.3%)
$40,000 - $80,000
13 (31.7%)
> $80,000
18 (43.9%)
Unknown
7 (17.1%)
Cancer Diagnosis
ALL
21 (51.2%)
7 (26%)
0.014
4 (9.8%)
0
Central Nervous System Tumor
3 (11.1%)
Sarcoma
4 (9.8%)
4 (14.8%)
Neuroblastoma
3 (7.3%)
Wilm’s Tumor
3 (7.3%)
6 (22.2%)
6 (22.2%)
Non-Hodgkin’s Lymphoma
1 (2.4%)
0
Hodgkin’s Lymphoma
1 (2.4%)
1 (3.7%)
Other
4 (9.8%)
CNS-Directed Treatment
CNS-Directed TreatmentC
25 (62.5%)
7 (25.9%)
No CNS-Directed Treatment
15 (37.5%)
20 (74.1%)
Treatment History
Chemotherapy Only
25 (61%)
6 (22.2%)
0.000
Chemotherapy and Radiation
14 (34.1%)
6 (22.2%)
No Chemotherapy or Radiation
2 (4.9%)
15 (55.6%)
0.554
3.6 ± 2.6 (0-12.7)
3.2 ± 2.7
Mean Age at Diagnosis ± SD (Range) in Years
0.004
12.0 ± 3.7 (6.714.5 ± 2.9
Mean Age at Time of Study Opening ± (Range)
18.99)
in Years
Mean Age at Study Completion ± SD (Range) in 12.8 ± 3.5 (6.7 –
18.99)
Years
Time Since Therapy Completion in YearsD
0-4
15 (38.5%)
0 (0%)
5-9
15 (38.5%)
6 (54.6%)
0.041
10-14
8 (20.5%)
4 (36.4%)
>15
1 (2.5%)
1 (9%)
A - Bold numbers indicate statistical significance.
B - Non-white includes African-American, Hispanic, Central American Indian and other.
C - CNS-Directed Therapy includes intrathecal chemotherapy or cranial radiation. In the group of
participants, twenty-one patients received intrathecal chemotherapy and six patients received cranial
radiation.
D – Years since therapy completion was determined using the date of study completion for
participants and using the date on which the study was opened for non-participants. Data about the
date of therapy completion was only available for 11 non-participants.
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African-American. One (2.4%) patient refused to answer and one (2.4%) was listed as
other (see Table 3).
Parents reported their total family income on the Family and Social History
Questionnaire. The majority of parents, eighteen (43.9%), listed their annual family
income as greater than 80,000 per year. Eight (19.5%) reported income of 60,000 to
80,000. Five (12.2%) listed their incomes as 40,000 to 60,000, and three (7.3%) as less
than 40,000 annually. Three (7.3%) patients refused to answer and four (9.8%) reported
that they did not know their average annual income (see Table 3).
The study population included a wide range of cancer diagnoses. Twenty-one
patients (51.2%) were diagnosed with acute lymphoblastic leukemia. Four patients
(9.8%) had been diagnosed with sarcomas and four patients (9.8%) with tumors of the
central nervous system. Three patients (7.3%) were diagnosed with each of the following
cancers: Neuroblastoma and Wilm’s tumor. Two patients (4.8%) were diagnosed with
lymphomas, one patient with Hodgkin’s Lymphoma and one patient with Non-Hodgkin’s
Lymphoma. Four patients (9.8%) had other cancers (see Table 3).
Of these patients participating in the study, twenty-five (61%) received only
chemotherapy. Fourteen (34.1%) of the patients received both chemotherapy and
radiation. Two (4.9%) patients received neither chemotherapy nor radiation as part of
their cancer treatment (see Table 3).
The group of participants was compared to those who declined participation in the
present study. There were no significant differences in the two populations in terms of
gender, ethnicity, or age at diagnosis. In the participant group twenty-three (56.1%) were
female, while in the non-participant group twelve (44.4%) were female. There was a
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significant difference in the age at testing. The mean age in the study population was
12.0 years, while the mean age at time of study opening in the non-participant group was
14.5 (p-value = 0.004) (see Table 3).
The set of diagnoses was significantly different (p-value = 0.014) when
comparing overall range of diagnoses for each group. The study population had a greater
percentage of patients with acute lymphoblastic leukemia (51.2%) than the nonparticipant group (25.9%). Diagnoses of Neuroblastoma (7.3% in the study population),
Wilm’s tumor (7.3%), and Non-Hodgkin Lymphoma (2.4%) were underrepresented in
the group of participants (14.8%, 22.2% and 22.2% respectively in the non-participant
group). Of the forty patients for which data was available, twenty-five (62.5%)
participants received central nervous system-directed therapy, which included either
cranial radiation or intrathecal chemotherapy, and fifteen (37.5%) did not. This was
different from the non-participant group, in which seven (25.9%) received central
nervous system-directed therapies and twenty (74.1%) did not. Analyses of treatment
and years since therapy completion in the non-participant group was confounded by
missing information, as complete data was available for only a minority of nonparticipants (see Table 3).
When analyzing the data in order to describe the study population, the mean
values in the sample were in the standard range reported for each survey instrument.
However, when examining percentage of impairment compared to the expected in a
normative population, there were significant differences. Therefore percentages of
impairment and their respective significance, as indicated by p-values less than 0.05, are
reported throughout the text and tables.
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Table 4 - Emotional Functioning as Measured by the Parent Version of the Behavior
Assessment Scale for Children, Second Edition (BASC-II), Stratified by GenderA
Norm
%

All patients
#/N

%

pvalue

Female
#/N

%

Male
pvalue

#/N

%

pvalue

Externalizing
16
Problems
5/40 12.5 0.670 3/22 13.6
1
2/18 11.1 0.756
Hyperactivity
16
5/40 12.5 0.670 2/22 9.1
0.562 3/18 16.7
1
Aggression
16
4/40
10 0.391 3/22 13.6
1
1/18 5.6
0.34
Conduct
16
Problems
7/40 17.5 0.828 4/22 18.2
0.77
3/18 16.7
1
Internalizing
16
Problems
11/40 27.5 0.053 9/22 40.9 0.005 2/18 11.1 0.756
Anxiety
16
7/40 17.5 0.828 5/22 22.7 0.382 2/18 11.1 0.756
Depression
16
13/40 32.5 0.008 9/22 40.9 0.005 4/18 22.2 0.515
Somatization
16
13/40 32.5 0.008 9/22 40.9 0.005 4/18 22.2 0.515
Behavioral
16
Symptoms Index
11/40 27.5 0.053 5/22 22.7 0.382 6/18 33.3 0.055
Atypicality
16
9/40 22.5 0.278 3/22 13.6
1
6/18 33.3 0.055
Withdrawal
16
12/40 30.0 0.027 8/22 36.4 0.017 4/18 22.2 0.515
Attention
16
Problems
11/40 27.5 0.053 5/22 22.7 0.382 6/18 33.3 0.055
Adaptive Skills
16
Composite
10/40 22.5 0.278 5/22 22.7 0.382 5/18 27.8 0.192
Adaptability
16
9/40 22.5 0.278 6/22 27.3 0.149 3/18 16.7
1
Social Skills
16
7/40 17.5 0.828 3/22 13.6
1
4/18 22.2 0.515
Leadership
16
8/40 20.0 0.515 4/22 18.2
0.77
4/18 22.2 0.515
Activities of
16
Daily Living
9/40 22.5 0.278 3/22 13.6
1
6/18 33.3 0.055
Functional
16
Communication
9/40 22.5 0.278 5/22 22.7 0.382 4/18 22.2 0.515
Significance is determined if the percentage of study patients with T scores ≥ 84 percentile (≤ 16
percentile for adaptive scales) is greater than the expected 16%.
A - Bold numbers indicate statistical significance.

The data from the BASC-II was analyzed to characterize impairments in
emotional functioning in the study population. Using the parent reports of their
children’s behavior on the BASC-II, 27.5% reported impairments in internalizing
symptoms, with clinically significant endorsement of symptoms of depression (32.5%),
somatization (32.5%) and withdrawal (30.0%). In addition, 27.5% showed impairments
in attention and 27.5% endorsed symptoms of impairment on the behavioral symptoms
index compared to normative populations (see Table 4).
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Table 5 - Neurocognitive and Executive Functioning as Measured by the Parent
Version of the Behavior Rating Index of Executive Functioning (BRIEF), Stratified
by GenderA
Norm
%

All Patients
p (vs.
#/N
%
norm)
8/38 21.1
0.05
13/38 34.2 0.000

Female
#/N

%

Male
p (vs.
norm)
0.052
0.003

#/N

%

p (vs.
norm)
0.238
0.005

Inhibit
10
5/21 23.8
3/17 17.6
Shift
10
7/21 33.3
6/17 35.3
Emotional
10
7/38 18.4 0.098 4/21 19.0 0.152 3/17 17.6 0.238
Control
BRI
10
12/38 31.5 0.000 7/21 33.3 0.003 5/17 29.4 0.022
Initiation
10
6/38 15.8 0.270 2/21 9.5
1
4/17 23.5 0.083
Working
10
13/37 35.1 0.000 6/21 28.6 0.014 7/16 43.7 0.0005
Memory
Planning
10
6/38 15.8 0.270 4/21 19.0 0.152 2/17 11.8 0.684
Organization
10
7/38 18.4 0.098 4/21 19.0 0.152 3/17 17.6 0.238
of Materials
Monitor
10
7/38 18.4 0.098 4/21 19.0 0.152 3/17 17.6 0.238
MCI
10
11/38 28.9 0.001 6/21 28.6 0.014 5/17 29.4 0.022
GEC
10
9/38 23.6 0.011 6/21 28.6 0.014 3/17 17.6 0.238
Significance is determined if the percentage of study patients with T scores ≥ 65 percentile is
greater than the expected 10%.
A - Bold numbers indicate statistical significance.

The parent BRIEF was also analyzed to describe neurocognitive functioning in
the study population. Parents reported impaired scores for 23.6% of the study population
on the Global Executive Composite (GEC) scale, which includes all of the subscales. For
the cohort of forty-one patients, 31.5% showed impaired scores on the Behavior
Regulation Index (BRI), with clinically significant endorsement of problems on the
inhibit (21.1%) and shift (34.2%) scales. On the Metacognition Index (MI), 28.9% of the
population showed impairment, with clinically significant scores on the memory subscale (35.1%) (see Table 5).
The results of the parent-version survey instruments were also divided into
subgroups of gender, age at diagnosis and age at study completion and analyzed for
comparison to further characterize the study population. When the results of the parentreport BASC-II were divided by gender, female patients (40.9%) endorsed more
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internalizing symptoms than male patients (11.1%), as confirmed by Fisher’s test (p =
0.073). Specifically, female patients endorsed more symptoms of depression (40.9%),
somatization (40.9%) and withdrawal (36.4%) than their male counterparts (22.22%,
22.22% and 22.22% respectively). Male patients endorsed more problems with attention
(33.3%), activities of daily living (33.3%) and overall impairment on the behavioral
symptoms index (33.3%) than female patients (22.7%, 13.6% and 22.7% respectively).
Fisher’s tests performed for this data were not clinically significant (see Table 4).
The results of the parent report of the BRIEF, when divided by gender, revealed
greater proportion of impairment in female patients on the GEC (28.6%) and BRI
(33.3%) than male patients (17.6% and 29.4% respectively). Male patients had slightly
higher percentage of problems with shift (35.3%) and memory (43.7%) than female
patients (33.3% and 28.6% respectively). However female patients endorsed more
problems with inhibition (23.8%) than male patients (17.6%). Fisher’s tests were run
comparing percentage of impairment in male and female patients, and revealed no
clinically significant differences (see Table 5).
When the results of the parent-report BASC-II were divided by age at diagnosis,
children diagnosed at greater than or equal to 3.5 years were reported to have more
symptoms of withdrawal (52.9%) than those diagnosed at younger ages (13%). This was
confirmed by Fisher’s test (p-value = 0.013). Children diagnosed in the older age group
also were reported on the parent BASC-II to have more symptoms of anxiety (35.3%),
depression (35.3%), atypicality (35.3%), internalizing problems (41.2%) and problems
with attention (41.2%), adaptability (35.3%), and on the overall behavioral symptoms
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Table 6 - Emotional Functioning as Measured by the Parent Version of the Behavior
Assessment Scale for Children, Second Edition (BASC-II), Stratified by Age at
DiagnosisA
Age at Diagnosis
< 3.5 yrs
≥ 3.5 yrs
p (vs.
p (vs.
%
#/N
%
#/N
%
norm)
norm)
Externalizing Problems
16
3/23
13
1.000 2/17 11.8
1.000
Hyperactivity
16
2/23
8.7
0.567 3/17 17.6
0.745
Aggression
16
2/23
8.7
0.567 2/17 11.8
1.000
Conduct Problems
16
3/23
13
1.000 4/17 23.5
0.336
Internalizing Problems
16
4/23 17.4 0.778 7/17 41.2
0.012
Anxiety
16
1/23
4.3
0.160 6/17 35.3
0.042
Depression
16
7/23 30.4 0.080 6/17 35.3
0.042
Somatization
16
8/23 34.8 0.022 5/17 29.4
0.174
Behavioral Symptoms Index
16
5/23 21.7 0.400 6/17 35.3
0.043
Atypicality
16
3/23
13
1.000 6/17 35.3
0.042
Withdrawal
16
3/23
13
1.000 9/17 52.9
0.000
Attention Problems
16
4/23 17.4 0.778 7/17 41.2
0.012
Adaptive Skills Composite
16
6/23 26.1 0.247 4/17 23.5
0.336
Adaptability
16
3/23
13
1.000 6/17 35.3
0.042
Social Skills
16
3/23
13
1.000 4/17 23.5
0.336
Leadership
16
5/23 21.7 0.400 3/17 17.6
0.745
Activities of Daily Living
16
6/23 26.1 0.247 3/17 17.6
0.745
Functional Communication
16
4/23 17.4 0.778 5/17 29.4
0.174
Significance is determined if the percentage of study patients with T scores ≥ 84
percentile (≤ 16 percentile for adaptive scales) is greater than the expected 16%.
A - Bold numbers indicate statistical significance.
Norm

index (35.3%) than patients diagnosed at ages younger than 3.5 (4.3%, 30.4%, 13%,
17.4%, 17.4%, 13%, and 21.7% respectively). Conversely, on the BASC-II, parents
reported that children diagnosed before age 3.5 showed more symptoms of somatization
(34.8%) than those diagnosed at older ages (29.4%). These results were not significantly
different by Fisher’s test (see Table 6).
When divided by age at study completion, parents reported that pre-adolescent
patients endorsed more symptoms of somatization (37.5%) than adolescent patients
(29.2%). However, adolescents were reported by their parents on the BASC-II to exhibit
more symptoms of depression (33.3%) and withdrawal (33.3%) than pre-adolescents.
These differences were not significant when compared by Fisher’s tests.
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Table 7 - Neurocognitive and Executive Functioning as Measured by the Parent
Version of the Behavior Rating Index of Executive Functioning (BRIEF), Stratified
by Age at Diagnosis and Age at Study CompletionA
Age at Diagnosis
< 3.5 yrs
≥ 3.5 yrs
#/N

%

p

#/N

%

Age at Study Completion
≤ 11 yrs
≥ 12 yrs
p

#/N

%

p

#/N

%

p

Inhibit
2/20 10.0 1.000 6/18 33.3 0.006 1/16 6.3
1
7/22 31.8
0.004
Shift
5/20 25.0 0.043 8/18 44.4 0.000 4/16 25.0 0.07 9/22 40.1 0.0001
Emotional
3/20 15.0 0.445 4/18 22.2 0.098 2/16 12.5 0.67 5/22 22.7
0.062
Control
BRI
5/20 25.0 0.043 7/18 38.9 0.001 3/16 18.6 0.21 9/22 40.1 0.0001
Initiation
2/20 10.0 1.000 4/18 22.2 0.098 2/16 12.5 0.67 4/22 18.2
0.27
Working
10/2
4/20 20.0 0.133 9/17 52.9 0.000 3/16 18.6 0.21
45.5
0
Memory
2
Planning
3/20 15.0 0.445 3/18 16.7 0.146 1/16 6.3
1
5/22 22.7
0.062
Org, of
3/20 15.0 0.445 4/18 22.2 0.098 3/16 18.6 0.21 4/22 18.2
0.27
Materials
Monitor
2/20 10.0 1.000 5/18 27.8 0.028 2/16 12.5 0.67 5/22 22.7
0.062
MCI
4/20 20.0 0.133 7/18 38.9 0.001 4/16 25.0 0.07 7/22 31.8
0.004
GEC
3/20 15.0 0.445 6/18 33.3 0.006 2/16 12.5 0.67 7/22 31.8
0.004
Significance is determined if the percentage of study patients with T scores ≥ 65 percentile is greater
than the expected 10%. P-value is as compared to the norm, which was 10% for each analysis. Org.
of Materials refers to Organization of Materials.
A - Bold numbers indicate statistical significance.

When results of the BRIEF were analyzed by age at diagnosis, parents reported a
higher percentage of impairment of working memory in children diagnosed at age 3.5 or
older (52.9%) than those in the younger age at diagnosis group (20.0 %). This clinically
significant difference was confirmed by Fisher’s test (p-value = 0.047). Children
diagnosed at age 3.5 or older also had more problems with inhibition (33.3%), shift
(44.4%), and monitor (27.8%) compared to the younger population (10%, 25% and 10%
respectively). Parents reported higher rates of impairment in children diagnosed at 3.5
years or older on the summary scales of the behavioral regulation index (38.9%),
metacognition index (38.9%), and global executive composite (33.3%) than in children
diagnosed before 3.5 years of age (25%, 20%, and 15% respectively) (see Table 7).
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Table 8 - Self-Report of Quality of Life as Measured by the Pediatric Quality of Life
Inventory (PedsQL), Stratified by GenderA
Norm
%

All Patients
#/N

%

p (vs.
norm)

Female
#/N

%

Male
p (vs.
norm)

#/N

%

p (vs.
norm)

Physical
15
13/40 32.5 0.006
9/22 40.9 0.002 4/18 22.2 0.333
Functioning
Emotional
14
12/40 30.0 0.009 10/22 45.5 0.0003 2/18 11.1
1
Functioning
Social
16
11/40 27.5 0.053
6/22 27.3 0.149 5/18 27.8 0.192
Functioning
School
17
12/40 30.0 0.035
6/22 27.3 0.249 6/18 33.3 0.106
Functioning
Psychosocial
16
10/40 25.0 0.129
7/22 31.8 0.071 3/18 16.7
1
Summary
Score
Total Score
17
13/40 32.5 0.018
8/22 36.4 0.023 5/18 27.8 0.214
Higher Z-scores indicate better quality of life. Significance is determined if the percentage
of study patients is greater than the expected percentile listed in the Norm column. The
expected percentiles change with each subscale.
A - Bold numbers indicate statistical significance.

The results of the self-report PedsQL were also compared to normative
populations in order to characterize quality of life functioning in the study population and
to prepare for analyses of the three aims. On the self-report PedsQL, 32.5% showed
impairments on the total score scale, with clinically significant impairments in emotional
(30.0%), social (27.5%), and school (30.0%) functioning. This indicated that the
impairments reported could affect any of the realms of quality of life (see Table 8).
The results of the self-report PedsQL were also divided into subgroups and
compared to healthy controls. When divided by gender, female patients showed more
impairment on the total score (36.4%) than male patients (27.8%). Female patients also
endorsed more clinically significant impairment on the emotional (45.5%) functioning
scales than male patients (11.1%), as confirmed by Fisher’s test (p = 0.035) (see Table 8).
When separated by age at diagnosis, children who were diagnosed at 3.5 years or
older reported greater impairment in every realm -- emotional functioning (33.3%), social
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Table 9 - Self-Report of Quality of Life as Measured by the Pediatric Quality of Life
Inventory (PedsQL), Stratified by Age at DiagnosisA
Age at Diagnosis
Norm

< 3.5 yrs

≥ 3.5 yrs

%

#/N

%

p
(vs. Norm)

#/N

%

p
(vs. Norm)

Physical Functioning

17

6/22

27.3

0.128

7/18

38.9

0.012

Emotional Functioning

16

6/22

27.3

0.113

6/18

33.3

0.031

Social Functioning

19

4/22

18.2

0.77

7/18

38.9

0.017

School Functioning

19

5/22

22.7

0.406

7/18

38.9

0.023

Psycho-social Summary Score

18

5/22

22.7

0.381

5/18

27.8

0.192

Total Score

18

6/22

27.3

0.249

7/18

38.9

0.023

Higher Z-scores indicate better quality of life. Significance is determined if the percentage of
study patients is greater than the expected percentile listed in the Norm column. The expected
percentiles change with each subscale.
A - Bold numbers indicate statistical significance.

functioning (38.9%) and school functioning (38.9%) than those diagnosed before age 3.5
(27.3%, 27.3%, 18.2%, 22.7% respectively). This was also reflected in greater
impairment in total score in older age at diagnosis (38.9%) than younger age at diagnosis
(27.3%) (see Table 9). When divided by age at evaluation, pre-adolescent patients
reported clinically significant percentages of impairment in emotional functioning
(33.3%) while adolescent patients did not (24% and 28% respectively).
The remaining sets of surveys -- the teacher-report and self-report versions of the
BASC-II, the teacher version of the BRIEF, and the parent version of the PedsQL -- were
also scored and compared to normative populations. The results of these instruments
were divided into subgroups and compared for differences. The data from these surveys
was mostly used to characterize the study population, and can be found in Appendix I for
further reference.
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Perceptions of Impairment and Inter-Rater Reliability
Key data from the different versions of each survey instrument were analyzed to
determine if there was inter-observer reliability and agreement. Differences in perception
of impairment based on the respondent were evaluated with kappa statistics, which
analyze agreement. First, agreement was analyzed on the attention subscale on the parent
and teacher versions of the BASC-II (see Appendix I for results of teacher-report BASCII). This analysis showed that of the seven patients rated as impaired by parents, teachers
rated 4 as impaired (kappa = 0.57, p = 0.0015), indicating moderate strength of
agreement with a significant p-value labeling this result as not due to chance alone (see
Table 10).
The parent and child versions of the BASC-II were also evaluated to determine if
the raters agreed on the attention and emotional functioning scales (see Appendix I for
results of the self-report BASC-II). When parents rated attention as impaired (N = 11),
children rated themselves as impaired 7 times (kappa = 0.59, p = 0.0001), indicating
moderate strength of agreement not due to chance. However, there was no strength of
agreement shown for the depression, anxiety, somatization, or internalizing symptoms
scales (see Table 10).
The parent and teacher versions of the BRIEF were analyzed to understand
perceptions of executive functioning (see Appendix I for results of the teacher-report
BRIEF). Of the 9 survivors rated as having problems with memory by parents, five were
rated as impaired by teachers (kappa = 0.61, p = 0.0006), showing substantial strength of
agreement not due only to chance. The level of agreement was moderate for shifting
behaviors, as parents rated children as having problems seven times and teachers also
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Table 10 - Inter-rater Reliability Between Different RespondentsA
KappaE
P-value
Perceptions of Impairment
Parent BASC vs. Teacher BASC
Attention
0.57
0.002
Parent BASC vs. Self-Report BASC
Depression
0.08
0.295
Anxiety
0.21
0.098
Attention
0.59
0.000
Somatization
0.10
0.265
Internalizing Symptoms
0.00
0.487
Parent BRIEF vs. Teacher BRIEF
Memory
0.61
0.001
Inhibition
0.05
0.3925
Shift
0.43
0.011
Planning
0.52
0.002
Organization of Materials
-0.07
0.672
Initiation
0.35
0.037
Monitor
0.17
0.191
Metacognition Index
0.52
0.002
Global Executive Composite
0.59
0.001
Parent PedsQL vs. Self-Report PedsQL
School Functioning
0.70
0.000
Emotional Functioning
0.48
0.001
Social Functioning
0.44
0.002
Self-Report PedsQL School Functioning vs. Teacher BRIEF
Memory
0.57
0.002
Planning
0.57
0.002
Organization of Materials
0.12
0.738
0.40
0.022
Initiation
A - Bold numbers indicate statistical significance.
E - Kappa Statistics were used to analyze the agreement against what might be
expected by chance alone. For these results, Kappa values from 0.41-0.60 were
considered moderate agreement and from 0.61-0.80 were considered substantial
agreement. Kappa values from 0.81-1.00 indicated almost perfect agreement.

rated impairment 3 times (kappa = 0.43, p = 0.011). In terms of problems with planning,
for the 2 patients parents rated as impaired, teachers rated both as impaired (kappa = 0.52,
p = 0.0016) indicating moderate strength of agreement despite small numbers. Of the 7
patients parents rated as having impairments on metacognition, 3 were also rated as
impaired by teachers (kappa = 0.52, p = 0.0015). Similarly, of the 5 patients parents
rated as having impairments on the global executive composite, 3 were rated as impaired
by teachers (kappa = 0.59, p = 0.0013). These results indicate moderate strength of
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agreement not due only to chance. There was no agreement shown in terms of inhibition,
organization of materials, initiation or monitor (see Table 10).
The parent and self-report versions of the PedsQL were analyzed to assess
variability in perceptions of quality of life and showed agreement in all realms (see
Appendix I for results of the parent-report PedsQL). The level of agreement was
substantial for impairment of school functioning, as of the 11 reports of impairment by
parents, children also rated impairment 9 times (kappa = 0.70, p = 0.000). Among the 15
patients reported as having impaired emotional functioning by parents, 8 children selfreported impairment (kappa = 0.48, p = 0.0013). Parents reported impairment in social
functioning in 15 patients, and of these 8 self-reported impairment (kappa = 0.44, p =
0.0023). These results show moderate agreement for emotional and social functioning
between parents and survivors not due to chance alone (see Table 10).
Due to the limitations of the surveys, in order to understand different perceptions
of school functioning between the child and the teacher, the self-report of school
functioning on the PedsQL was compared to the teacher version of the BRIEF (see
Appendix I for results of the teacher-report BRIEF). Among those patients reporting
impaired school functioning (N = 7), teachers reported impairments in memory in 4
patients (kappa = 0.56, p = 0.0019) and impairments in planning and organization in 4
patients (kappa = 0.56, p = 0.0019). These results indicate moderate strength of
agreement not due to chance. There was no agreement between self-report of impaired
school functioning and teacher perception of problems with organization of materials or
initiation (see Table 10).
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Co-morbidities between Neurocognitive and Emotional Impairments
Data was compared between survey instruments in order to determine which
emotional problems tended to co-exist alongside neurocognitive difficulties. The anxiety
and depression scales on the parent BASC-II were compared to executive functioning
scales on the parent version of the BRIEF. Among the 14 patients reported by their
parents to have impairments in either anxiety or depression on the BASC-II, 57.1% (N =
8, p-value = 0.039) had co-existing impairment in shift, defined as ability to freely shift
between activities, on the BRIEF. Parent reports did not show that anxiety and
depression co-existed with memory, organization of materials, initiation, monitor,
inhibition or the metacognition index (see Table 11).
Among the 13 patients reported to have impairments in somatization on the
BASC-II, 61.5% (N = 8, p = 0.03) had co-existing impairments in memory, 69.2% (N =
9, p = 0.003) had co-existing impairments in shift, and 53.9% (N = 7, p = 0.028) had coexisting impairments on the metacognition index on the BRIEF. Within the group of
parent reports of impaired somatization on the BASC-II, parents did not rate impairments
in organization of materials, initiation, monitor, or inhibition as significantly impaired on
the BRIEF (see Table 11).
Of the 12 patients rated by their parents as impaired on the withdrawal scale on
the BASC-II, 66.7% (N = 8, p = 0.011) had co-existing impairments in memory, 66.7%
(N = 8, p = 0.011) had co-existing impairments in shift and 58.3% (N = 7, p = 0.018) had
co-existing impairments on the metacognition index shift. Within this group there was no
co-existence shown with organization of materials, initiation, monitor and inhibition as
significantly higher rates of impairment than no impairment (see Table 11).
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Table 11 - Co-existence of Impairments in Emotional and Neurocognitive
OutcomesA
Co-Morbidities: Parent BASC-II vs. Parent BRIEF
ProportionF (%)
P-value
Anxiety and Depression vs.
Memory
42.9
0.723
Organization of Materials
35.7
0.080
Initiation
21.4
0.653
Shift
57.1
0.039
Monitor
35.7
0.080
Inhibition
21.6
0.215
Metacognition Index
50.0
0.063
Somatization vs.
Memory
61.5
0.030
Organization of Materials
38.5
0.072
Initiation
46.2
0.001
Shift
69.2
0.003
Monitor
38.5
0.072
Inhibition
30.8
0.413
Metacognition Index
53.9
0.028
Withdrawal vs.
Memory
66.7
0.011
Organization of Materials
33.3
0.183
Initiation
41.7
0.009
Shift
66.7
0.010
Monitor
50.0
0.002
Inhibition
33.3
0.394
Metacognition Index
58.3
0.018
Internalizing Symptoms vs.
Memory
45.5
0.475
Organization of Materials
36.4
0.163
Initiation
27.3
0.335
Shift
72.7
0.006
Monitor
45.5
0.016
Inhibition
36.4
0.203
Metacognition Index
54.6
0.051
A - Bold numbers indicate statistical significance.
F - Proportion is described as the following: of those who are reported by parents to be
impaired on the BASC-II, the proportion also reported by parents as impaired on the
BRIEF. For example, among the 14 patients reported to have impairments in either
anxiety or depression on the BASC-II, 57.1% (N = 8, p-value = 0.039) had co-existing
impairment in shift on the BRIEF. Fisher’s exact test was used for this analysis.

Among the 11 patients whose parents reported impairment in internalizing
symptoms on the BASC-II, 72.7% (N = 8, p = 0.006) had co-existing impairments in shift
on the BRIEF. Within this group of parent reports there was no co-existing impairment
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shown in memory, organization of materials, initiation, monitor, inhibition or on the
metacognition index (see Table 11).

Predictors of Poor Quality of Life
An unadjusted and an adjusted logistic regression was performed in order to
determine the extent to which factors of female gender, adolescent age at study
completion, parent-rating of impaired metacognition and parent-rating of endorsement of
internalizing symptoms were associated with self-perception of poor quality of life.
Specifically, the realms of school functioning, emotional functioning and social
functioning were examined from the results of the self-report PedsQL. Age at study
completion was chosen instead of age at diagnosis due to high correlation between the
two realms and better data in the literature about the significance of age at testing in
revealing late effects of childhood cancer treatments.
Worse school functioning was predicted by impaired metacognition on the parent
BRIEF in the unadjusted model (OR = 23, CI = 3.52-150.48, p = 0.001). When adjusted
for the other predictors, the odds ratio (OR) increased (OR = 33.5, CI = 3.2-351.39, p =
0.003), indicating that metacognition was a very strong predictor of poor school
functioning. Female gender, age at testing and parent rated impairment of internalizing
symptoms on the BASC-II were not good predictors of school functioning (see Table 12).
Poor emotional functioning was also predicted by parent-rating of impaired
metacognition on the BRIEF on the unadjusted model (OR = 5.25, CI 1.11-24.91, p =
0.037). When adjusted for the other predictors, the odds ratio increased (OR = 11.48, CI
= 1.07-123.17, p = 0.044), indicating that impaired metacognition was a strong
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Table 12 - Predictors of Self-Report of Impaired Quality of Life Functioning Among
Survivors, Unadjusted and Adjusted Regression AnalysisA
Unadjusted
OR (95% CI)
P-value

Adjusted
OR (95% CI)

P-value

School Functioning
Female Gender
0.79 (.02-3.12)
0.73
1.18 (0.18-7.61)
0.86
Age at Testing >= 12
1.57 (0.37-6.61)
0.54
1.39 (0.22-8.94)
0.73
Parent-rated Impairment of
23.00 (3.52-150-48) 0.001 33.51 (3.2-351.39) 0.003
MetacognitionG
Parent-rated Impairment in Internalizing
1.50 (0.33-6.82)
0.6
0.34 (0.03-4.39)
0.41
SymptomsH
Emotional Functioning
Female Gender
7.50 (1.35-41.72) 0.021 15.58 (1.41-172.85) 0.025
Age at Testing >= 12
0.93 (0.23-3.78)
0.92
0.56 (0.09-3.53)
0.54
Parent-rated Impairment of
5.25 (1.11-24.91) 0.037 11.48 (1.07-123.17) 0.044
MetacognitionG
Parent-rated Impairment in Internalizing
5.00 (1.05-23.79) 0.043
2.11 (0.33-13.58)
0.43
SymptomsH
Social Functioning
Female Gender
1.03 (0.25-4.24)
0.97
1.07 (0.17-6.77)
0.94
Age at Testing >= 12
0.75 (0.18-3.12)
0.69
0.38 (0.06-2.48)
0.31
Parent-rated Impairment of
13.42 (2.40-74.89) 0.003 13.94 (2.00-97.22) 0.008
MetacognitionG
Parent-rated Impairment in Internalizing
3.33 (0.72-15.54) 0.125
2.17 (0.3-15.64)
0.44
SymptomsH
A - Bold numbers indicate statistical significance.
G - As measured on the parent-report version of the Behavior Rating Inventory of Executive
Function.
H - As measured on the parent-report version of the Behavior Assessment Scale for Children,
Second Edition.

predictor of poor emotional functioning. Worse emotional functioning was predicted by
female gender on the unadjusted model (OR = 7.5, CI = 1.35-41.72, p = 0.021) and when
adjusted for the other predictors (OR = 15.58, CI = 1.41-172.85, p = 0.025), indicating
that female gender was also a strong predictor for poor emotional functioning. Poor
emotional functioning was predicted by parent-rating of endorsement of internalizing
symptoms on the BASC-II in the unadjusted model (OR = 5, CI 1.05-23.79, p = 0.043).
However, when adjusted for other factors, impairment in internalizing symptoms was not
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as good of a predictor (OR = 2.11, CI = 0.33-13.58, p = 0.43). Age at testing was not a
good predictor of emotional functioning (see Table 12).
Poor social functioning was only predicted by impaired metacognition as reported
by parents on the BRIEF. On the unadjusted model, impaired metacognition predicted
poor social functioning (OR = 13.42, CI = 2.40-74.89, p = 0.003), and this remained true
when adjusted for the other predictors (OR = 13.94, CI = 2.00-97.22, p = 0.008). Poor
self-report of social functioning was not predicted by age at testing, female gender, or
parent rated impairment of internalizing symptoms on the BASC-II (see Table 12).
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Discussion
In this single institution cross-sectional study of forty-one childhood cancer
survivors who were simultaneously assessed for neurocognitive processing, emotional
functioning, and quality of life, a better understanding of psychosocial functioning in
childhood cancer survivors was obtained. This was accomplished through reaching the
three proposed aims of the study.
In accomplishing the first aim of the study, modest inter-observer variability was
found, especially among indexes of emotional symptoms. Moderate levels of agreement
were found between parent and teacher reporting on the BASC-II and BRIEF in terms of
attention, memory, ability to freely shift between behaviors, planning, metacognition and
global executive functioning. However, when reporting inhibition, monitoring and
initiation of behaviors, and organization of materials, agreement was not shown.
Similarly there was moderate strength of agreement in memory and planning between
teacher perceptions of executive functioning on the BRIEF and self-report of school
functioning on the PedsQL, but reports of other realms of executive functioning did not
show agreement.
These results reveal differences in perception between reports from teachers and
reports from parents and patients. Overall, teachers did not report as many deficits as
parents or children. This could indicate that the problems children report are sub-clinical
or potentially partially compensated for by diligent effort, and therefore are unable to be
perceived by teachers in the school setting. Internalizing symptoms and psychosocial
deficits may be more difficult for teachers to assess, as they only see children in the
limited school environment. Similarly, given the activities at school, problems with
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memory and attention may be easier to perceive than impairments in other realms of
executive functioning, such as problems with initiation, inhibition, shift, planning and
organization. Supporting the findings of other studies, the results of the current study
indicate that survivors’ deficits are less pronounced in some settings than others (19, 41).
Additionally, these results could also reveal that teachers are not getting to know their
students well enough. Teachers may need to delve deeper with cancer survivors to
ensure that they do not miss symptoms or problems with which the students could benefit
from help. Due to varying expression of symptoms in different settings and the
variability in perceptions of impairment between teachers and parents and children,
feedback about children’s well-being from a variety of complementary sources is
necessary to fully assess functioning.
Parent and self-reporting also lacked agreement in some realms of functioning. In
analyses of emotional symptoms on the BASC-II, there was moderate agreement only on
the attention scale. Inter-rater variability existed for the remaining emotional symptom
scales, such as depression, anxiety, somatization, and internalizing symptoms. On the
PedsQL, however, there was agreement between parents’ perceptions and children’s selfperceptions of their quality of life in every area of functioning. Despite the small sample
size, reports of school functioning showed substantial agreement and reports of emotional
and social functioning showed moderate agreement by kappa statistics.
Inter-rater agreement was found for quality of life functioning, but not for specific
emotional symptoms. Children perceive that they are not doing well, and parents tend to
agree with them. However, when parents recognize specific internalizing symptoms
exhibited by their children, the survivors do not report the same impairment. This could
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represent a lack of ability to definitively identify symptoms, even when children sense
poor quality of life. As Wheeler and Ladd described, parents’ perceptions of ability in
performing specific tasks correlates better with children’s actual abilities than do
children’s own perceptions (47). Children may not always have the capacity to pinpoint
specific deficits, but are able to sense overall deficit. Previous studies have also shown
that childhood cancer survivors feel more apprehension and tension than age-matched
peers (17) and often underestimate their abilities (44, 45). The results of the current
study may therefore indicate a tendency to overestimate poor quality of life, even when
children do not endorse specific symptoms, due to increased levels of apprehension.
However independent of cause, it is important to understand children’s self-perceptions
of their feelings because this determines their self-efficacy and subsequent behaviors.
These results could also indicate over-reporting of specific symptoms by parents
due to their own biases. Parents are affected by a child having had cancer, as evidenced
by more reported symptoms of post-traumatic stress disorder in mothers of survivors than
parents of healthy children (56, 57). Parents may, when completing surveys about their
children’s behaviors, overestimate the presence of symptoms. This could stem from
knowledge that their child has had an illness experience or the subsequent hypervigilance instilled by parents experiencing post-traumatic stress. Significant associations
between survivors’ psychological and behavioral adjustment and parental psychological
distress and coping strategies have previously been reported (58). A parent may perceive
symptoms in a child as a projection of his or her own psychosocial functioning and
feelings about a situation. Given the combination of children’s potential deficits in
identifying or overestimating functioning and parent’s own biases based on their
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experiences, the results of this study highlight the need to include perceptions of
functioning from a variety of sources in order to fully understand a survivor’s emotional
and social state.
Beyond exhibiting the need for multiple perceptions to determine functioning, the
current study provides a better understanding of impairments by detailing co-morbidities
of deficits. In reaching the second aim of the study, the present research showed that, as
a whole, neurocognitive and emotional difficulties did not co-exist. Impairments of
internalizing symptoms and of anxiety and depression co-existed only with impairments
in shift and not with any other realm of executive functioning. More targeted emotional
symptoms, such as symptoms of somatization and social withdrawal, co-existed with
problems with memory, shift, initiation and coordination of problem-solving behaviors.
In the overall population, anxiety and depression often coincide with social withdrawal
and symptoms of somatization (11, 12). However, the current study indicates that
childhood cancer survivors who exhibit problems with executive functioning might be
more socially withdrawn and over-sensitive to physical complaints, but do not exhibit
signs of anxiety or depression. These results help elucidate reasons behind specific
emotional impairments. Symptoms of somatization or social withdrawal may stem from
underlying difficulties with neurocognition, as children are self-conscious about their
impaired executive functioning. However these neurocognitive deficits do not result in
clinically significant anxiety or depression. Knowledge of these co-morbidities can be
used to determine targeted treatments for different sets of impairments.
The ultimate downstream outcome of these deficits, survivor perception of quality
of life, was measured by the self-report PedsQL and used to accomplish the study’s third
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aim. Interestingly, neurocognitive impairment was again the causative factor.
Neurocognitive deficits, as measured by the metacognition index on the BRIEF, were
consistently associated with worse school, emotional, and social quality of life. In the
present study, problems with metacognition, an analysis of a child’s ability to plan and
initiate problem-solving, were shown to profoundly impact the child’s self-perception of
his or her overall competence. As Bandura reported in 1977, self-efficacy is impacted by
the child’s experiences, which ultimately shapes his or her behaviors and coping
mechanisms (46). Neurocognitive problems clearly play a role in a child’s experiences.
Problems with neurocognition and executive functioning can have a direct impact on
academic performance, and therefore self-perception of school functioning. Emotional
functioning may be depressed due to a child’s awareness of and feelings about his or her
deficits in neurocognition, and from the social withdrawal and symptoms of somatization
that co-exist with neurocognitive problems.
Similarly, children may feel less capable or socially awkward because of their
difficulties with executive functioning, and this can impact self-esteem, interactions with
peers and, eventually, overall social functioning. Previous studies have describe that, as a
whole, childhood cancer survivors have fewer friends, are less satisfied with their
relationships, and spend more time by themselves than their peers (19, 24). The current
study showed that impairments in withdrawal co-exist with neurocognitive difficulties
and problems with executive functioning predict poor social functioning. Self-efficacy,
here measured by the self-report PedsQL, drives social competence. Survivors who
suffer from neurocognitive deficits may feel less comfortable with themselves, creating a
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tendency toward social withdrawal. This ultimately results in poor emotional and social
functioning that may impact survivors’ quality of life as a whole.
Impaired metacognition was a stronger predictor of emotional quality of life than
endorsement of emotional symptoms as measured by the BASC-II. While impaired
internalizing symptoms on the BASC-II predicted poor emotional functioning in the
unadjusted analysis, this did not remain true when adjusted for other factors.
Endorsement of emotional symptoms also did not predict worse school or social
functioning. Feelings of anxiety, depression, withdrawal and somatization can clearly
impact a child’s emotional quality of life. However these symptoms are neither the only
nor the greatest cause of dissatisfaction with emotional functioning. Interventions
targeting internalizing symptoms may help improve emotional quality of life, but coexisting deficits need to be screened for to ensure proper treatment for these patients.
Additional research is necessary to further characterize and understand the impact of
these symptoms on childhood cancer survivors.
Unlike endorsement of internalizing symptoms, female gender was found to be a
predictor of poor emotional functioning in both the unadjusted and adjusted analyses.
Parents reported that female patients endorsed more internalizing symptoms and
problems with behavioral regulation and inhibition than male patients, and female
patients and their parents both reported worse quality of life functioning. This is
consistent with previous studies reporting that female patients endorse more internalizing
symptoms, including depression, anxiety and somatic distress (7, 8, 14, 59). However
these results also reveal that not only do female patients report more late effects than
male patients, but these deficits are also correlated with impaired self-perception of
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emotional quality of life. Due to societal norms, female patients may be more willing to
admit to problems with emotional functioning than male patients, which could bias these
results. Alternatively, female patients may internalize their illness experience in different
ways than male patients, ultimately impacting their ability to cope and their emotional
quality of life. However, independent of the reason behind these results, emotional
functioning is highlighted as an area of deficit that needs to be targeted in female
survivors.
Age at study completion was also analyzed, and neither adolescent nor preadolescent age at study completion was shown to be a predictor of self-perception of poor
quality of life. These results were surprising, as parents reported more impairment in
quality of life functioning, as well as more symptoms of withdrawal, anxiety, depression,
atypical behaviors and internalizing symptoms, in adolescent patients than in preadolescent patients. However, it should be noted that adolescent patients did not selfreport these same results, and self-report of quality of life was used to determine
predictors of functioning. Adolescents may underreport difficulties or may not be as
influenced by deficits as parents perceive them to be. In 1982 Harter theorized that upon
entering junior high school, due to the social and academic changes of this time period,
children lose a percentage of their ability to accurately self-perceive their competence
(48). This theory could explain the discrepancy in parent and child reporting, as well as
the conclusion that age was not a predictor of poor quality of life. Further work is
necessary to understand how patients of different ages view their quality of life and if
interventions should be altered depending on patient age.
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Due to a participation rate of only 53.2% and the small sample size, the authors of
the current study were cautious about reporting frequencies of specific outcomes as being
able to be generalized to both HEROS Clinic patients and all childhood cancer survivors.
Therefore, a focus was placed on case-case comparisons rather than reports of overall
risk. Because of the heterogeneous cancer treatments received by patients in the sample,
it was not possible to examine the role of various treatment characteristics in greater
detail. Instead, patients were grouped by broad categories based on if they had received
cranial radiation or intrathecal chemotherapy.
Patients who had received central nervous system-directed treatment were
reported to have fewer problems with both school maladjustment and attitude towards
teachers. These results are not consistent with previous literature, which indicates
increased risk for psychological and social difficulties in patients who received cranial
radiation or intrathecal methotrexate (8, 33). However, studies have also indicated that
more intense or prolonged treatment is associated with poorer adjustment and greater
endorsement of symptoms of psychological distress (60, 61). Treatment intensity and
duration were not analyzed in the current study, and could be confounding factors.
Additionally, these therapies may render children more quiet and passive, making it more
difficult for teachers, or even parents, to observe deficits. Further analyses with the data
reported here should take advantage of the simultaneous analysis of neurocognitive,
emotional and quality of life functioning, one of the great strengths of the current study.
Central nervous system-directed therapies should be evaluated as a predictor of worse
self-report of quality of life in this population.
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It is important to note the limitations of the current study. Participation suffered
from a high rate of passive refusal. The majority of non-participants passively declined
participation by neither returning the surveys mailed to them nor scheduling clinic
appointments. Recruitment by mail was inefficient, as only 13% of those contacted
participated by mail, and the number of surveys returned by teachers was small, with only
twenty-seven packets returned. It is unknown if patients did not respond by mail due to
lack of interest in the study or for other reasons. When families completed surveys at
home, they often reported forgetting about the study and needing reminders to return their
answers. This may indicate that patients to whom packets were mailed simply
overlooked the study rather than actively deciding not to participate. Of those patients
who did actively decline, the reasons cited were that the parent did not desire for the child
to have to think about the psychosocial side effects of his or her cancer or that the child
was not interested in participating in a study.
These reasons for declining of participation may highlight possible biases of the
study population and of patients who choose to enroll in the HEROS Clinic. As
evidenced by the range of household incomes, the patients who attend the HEROS clinic
tend to be middle-class, which is not representative of the entire population of survivors
of childhood cancer. Those who choose to participate may be more comfortable with
their current quality of life and therefore willing to think about the issues raised by the
surveys. Alternatively, families of patients who attend clinic and agreed to complete the
surveys may exhibit and observe more impairment, and therefore desired to participate in
order to assist in discovering helpful interventions. The current study may represent two
ends of a spectrum and may under-represent patients with milder deficits that could play

57
a different role in quality of life than is reported in this study. The current study also
over-represents patients diagnosed with acute lymphoblastic leukemia compared to the
non-participant group, which may have affected the results of the study.
Despite these limitations, the current study provides an important addition to the
literature about emotional and psychosocial functioning in childhood cancer survivors. In
accomplishing three aims, this study provides a better understanding of which symptoms
endorsed by survivors have the greatest impact on how patients perceive their quality of
life. The current study shows inter-observer variability, especially among indexes of
emotional symptoms, indicating a need to obtain and understand perspectives from
multiple reporters to determine areas of deficit and true levels of functioning. When
taking care of survivors of childhood cancer, clinicians need to assess functioning from a
variety of angles in order to fully address the needs of their patients. Additionally, the
current study reveals that certain neurocognitive and emotional deficits co-exist, while
others do not. Problems with memory, shift, initiation, and coordination of problemsolving behaviors co-exist with symptoms of somatization and social withdrawal, but not
with anxiety and depression. Further, it is the neurocognitive rather than emotional
symptoms that are shown to be key predictors of how child-age survivors perceive their
quality of life after therapy. These results indicate that problems in specific areas of
executive functioning may help to explain somatization and social withdrawal behaviors,
as well as poor quality of life in survivors. Clinicians need to screen for co-morbidities in
survivors who present with specific emotional or neurocognitive deficits in order to fully
address both these impairments and issues of quality of life.
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Despite the recognition of late effects of treatment for childhood cancer, the
impact of these outcomes on children’s overall well-being has remained unclear. The
primary goal of therapy for childhood cancer is to cure the malignancy. However, as
cure rates improve, the concept of survivorship has expanded to include not only cure,
but also global functioning after treatment. Closely examining neurocognitive outcomes
and showing that these deficits tend to predict self-reported worse global functioning, the
current study helps develop a better understanding of quality of life in childhood cancer
survivors. Further research analyzing parent, teacher and self-report in a larger sample
size would continue to clarify the discordance between perceptions of functioning and the
benefits of these differences to patient care. Furthermore, studies analyzing the effects of
neurocognitive deficits on specific areas of global functioning could continue to elucidate
co-morbidities of symptoms and ultimately determine treatments that can help survivors
optimize their quality of life.
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Appendix I
Self-Report and Teacher-Report of Emotional Functioning on the BASC-II
Using the self-report versions of the BASC-II, there were no realms in which the
percentage of impairment was statistically significant compared to the normative
populations. When divided by gender, patients did not report any symptoms of
impairment at significantly higher rates than the published norms. On the self report
BASC-II children diagnosed at age 3.5 or older reported higher rates of problems with
attention (33.3%) and hyperactivity (33.3%) compared to those diagnosed at younger
ages (15% and 15% respectively). This was not significant by Fisher’s test (p = 0.26).
By teacher report, patients did not show statistically significant impairment on
any scale. When comparing female and male patients, a Fisher’s test revealed a
statistically significant difference on the withdrawal scores (p = 0.047). On the self and
teacher versions of the BASC-II there were no statistically significant symptoms reported
when divided by age at study completion.
When divided by history of central nervous system-directed therapy and
comparing the means for each population, children who had received either cranial
radiation or intrathecal chemotherapy reported fewer symptoms of school maladjustment
(p value = 0.037) and problems with their attitudes towards teachers (p-value = 0.019)
than those who did not.

Teacher-Report of Executive Functioning on the BRIEF
As reported on the teacher version of the BRIEF, 28% of patients showed
impairments on the initiation subscale. Data analysis did not reveal any other realms in
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which there was statistically significant impairment compared to the normative
populations. When divided by gender, male patients endorsed more problems with
initiation (35.7%) and planning (28.6%) than female patients (18.2% and 9.1%
respectively). Fisher’s tests comparing male and female patients on these scales did not
reveal statistically significant differences.
When divided by age at diagnosis, teachers reported higher rates of impairment in
children diagnosed at age 3.5 years or older on the inhibit (30.8%), shift (30.8%) and
initiation (30.8%) subscales, and on the BRI (30.8%) summary scale (compared to 0%,
0%, 25% and 0% respectively in the younger population at diagnosis). When separated
by age at evaluation, teachers reported more endorsement of problems with shift (28.6%),
initiation (35.7%), and planning (28.6%) in the adolescent population compared to preadolescents (0%, 18.2% and 9.1% respectively). Teachers also revealed significant
percentages of impairment in adolescent patients on the BRI (28.6%) and GEC (28.6%).
When analyzed by Fisher’s tests, no statistically significant differences were found.

Parent-Report of Quality of Life Functioning on the PedsQL
On the parent report of survivors’ quality of life on the PedsQL, 36.6% of patients
had impaired total scores and 34.1% had impaired psychosocial health summary scale
scores. Analysis of the study population revealed statistically significant proportion of
impairment on the physical (29.3%), emotional (34.1%), and social (39.0%) functioning
scales. When divided by gender, female patients endorsed more impairment in overall
quality of life (39.1%), emotional functioning (39.1%) and psychosocial health summary
scale (34.7%) compared to their male counterparts (33.3%, 27.8% and 33.3%
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respectively). Male patients, however, showed greater endorsement of impairment in
social functioning (44.4%) than female patients (34.7%). Fisher’s tests did not show any
statistically significant differences between male and female patients.
When divided by age at diagnosis, parents reported greater impairment of social
functioning (44.4%) and on the psychosocial summary score (44.4%) and total score
(44.4%) scales for children diagnosed at 3.5 years or older compared to those diagnosed
at younger ages (34.8%, 26.1% and 30.4% respectively). Children diagnosed before age
3.5, however, endorsed greater difficulty with emotional functioning (34.8%) than those
diagnosed at older ages (33.3%). When separated by age at study completion, adolescent
patients showed more impairment in emotional functioning (36%) and social functioning
(40%) and on the psychosocial (36%) and total (36%) score scales than pre-adolescent
patients (31.3%, 37.5%, 31.3% and 37.5% respectively). There were no statistically
significant differences in impairment when analyzed by Fisher’s tests.

62
References
1.

Maunsell, E., Pogany, L., Barrera, M., Shaw, A.K., and Speechley, K.N.
2006. Quality of life among long-term adolescent and adult survivors of
childhood cancer. J Clin Oncol 24:2527-2535.

2.

Speechley, K.N., Barrera, M., Shaw, A.K., Morrison, H.I., and Maunsell, E.
2006. Health-related quality of life among child and adolescent survivors of
childhood cancer. J Clin Oncol 24:2536-2543.

3.

Blaauwbroek, R., Groenier, K.H., Kamps, W.A., Meyboom-de Jong, B., and
Postma, A. 2007. Late effects in adult survivors of childhood cancer: the need
for life-long follow-up. Ann Oncol 18:1898-1902.

4.

Friedman, D.L., and Meadows, A.T. 2002. Late effects of childhood cancer
therapy. Pediatr Clin North Am 49:1083-1106, x.

5.

Hudson, M.M., Mertens, A.C., Yasui, Y., Hobbie, W., Chen, H., Gurney,
J.G., Yeazel, M., Recklitis, C.J., Marina, N., Robison, L.R., et al. 2003.
Health status of adult long-term survivors of childhood cancer: a report from
the Childhood Cancer Survivor Study. Jama 290:1583-1592.

6.

Ross, L., Johansen, C., Dalton, S.O., Mellemkjaer, L., Thomassen, L.H.,
Mortensen, P.B., and Olsen, J.H. 2003. Psychiatric hospitalizations among
survivors of cancer in childhood or adolescence. N Engl J Med 349:650-657.

7.

Boman, K.K., and Bodegard, G. 2004. Life after cancer in childhood: social
adjustment and educational and vocational status of young-adult survivors. J
Pediatr Hematol Oncol 26:354-362.

8.

Zebrack, B.J., Zeltzer, L.K., Whitton, J., Mertens, A.C., Odom, L., Berkow,
R., and Robison, L.L. 2002. Psychological outcomes in long-term survivors of
childhood leukemia, Hodgkin's disease, and non-Hodgkin's lymphoma: a
report from the Childhood Cancer Survivor Study. Pediatrics 110:42-52.

9.

Langeveld, N.E., Stam, H., Grootenhuis, M.A., and Last, B.F. 2002. Quality
of life in young adult survivors of childhood cancer. Support Care Cancer
10:579-600.

10.

Stam, H., Grootenhuis, M.A., and Last, B.F. 2001. Social and emotional
adjustment in young survivors of childhood cancer. Support Care Cancer
9:489-513.

11.

Cavusoglu, H. 2001. Depression in children with cancer. J Pediatr Nurs
16:380-385.

63
12.

Kaplan, S.L., Busner, J., Weinhold, C., and Lenon, P. 1987. Depressive
symptoms in children and adolescents with cancer: a longitudinal study. J
Am Acad Child Adolesc Psychiatry 26:782-787.

13.

Schultz, K.A., Ness, K.K., Whitton, J., Recklitis, C., Zebrack, B., Robison,
L.L., Zeltzer, L., and Mertens, A.C. 2007. Behavioral and social outcomes in
adolescent survivors of childhood cancer: a report from the childhood cancer
survivor study. J Clin Oncol 25:3649-3656.

14.

Zebrack, B.J., Gurney, J.G., Oeffinger, K., Whitton, J., Packer, R.J.,
Mertens, A., Turk, N., Castleberry, R., Dreyer, Z., Robison, L.L., et al. 2004.
Psychological outcomes in long-term survivors of childhood brain cancer: a
report from the childhood cancer survivor study. J Clin Oncol 22:999-1006.

15.

Moleski, M. 2000. Neuropsychological, neuroanatomical, and
neurophysiological consequences of CNS chemotherapy for acute
lymphoblastic leukemia. Arch Clin Neuropsychol 15:603-630.

16.

Fisch, M. 2004. Treatment of depression in cancer. J Natl Cancer Inst
Monogr:105-111.

17.

Bauld, C., Anderson, V., and Arnold, J. 1998. Psychosocial aspects of
adolescent cancer survival. J Paediatr Child Health 34:120-126.

18.

Recklitis, C., O'Leary, T., and Diller, L. 2003. Utility of routine psychological
screening in the childhood cancer survivor clinic. J Clin Oncol 21:787-792.

19.

Spirito, A., Stark, L.J., Cobiella, C., Drigan, R., Androkites, A., and Hewett,
K. 1990. Social adjustment of children successfully treated for cancer. J
Pediatr Psychol 15:359-371.

20.

Vannatta K, G.M., Short A, Noll RB. 1998. A controlled study of peer
relationship of children surviving brain tumors: Teacher, peer and selfratings. Journal of Pediatric Psychology 23:279-287.

21.

Nagarajan, R., Neglia, J.P., Clohisy, D.R., Yasui, Y., Greenberg, M., Hudson,
M., Zevon, M.A., Tersak, J.M., Ablin, A., and Robison, L.L. 2003. Education,
employment, insurance, and marital status among 694 survivors of pediatric
lower extremity bone tumors: a report from the childhood cancer survivor
study. Cancer 97:2554-2564.

22.

Elkin, T.D., Phipps, S., Mulhern, R.K., and Fairclough, D. 1997.
Psychological functioning of adolescent and young adult survivors of
pediatric malignancy. Med Pediatr Oncol 29:582-588.

64
23.

Barrera, M., Shaw, A.K., Speechley, K.N., Maunsell, E., and Pogany, L.
2005. Educational and social late effects of childhood cancer and related
clinical, personal, and familial characteristics. Cancer 104:1751-1760.

24.

Gray, R.E., Doan, B.D., Shermer, P., FitzGerald, A.V., Berry, M.P., Jenkin,
D., and Doherty, M.A. 1992. Psychologic adaptation of survivors of
childhood cancer. Cancer 70:2713-2721.

25.

Rait, D., Ostroff, JS, Smith, K. 1992. Lives in a Balance: Perceived Family
Functioning and the Psychosocial Adjustment of Adolescent Cancer
Survivors. Family Process 31:383-397.

26.

Kazak, A., Meadows, AT. 1989. Families of Young Adolescents Who Have
Survivors Cancer: Social-Emotional Adjustment, Adaptability, and Social
Support. Journal of Pediatric Psychology 14:175-191.

27.

Byrne, J., Fears, T.R., Steinhorn, S.C., Mulvihill, J.J., Connelly, R.R., Austin,
D.F., Holmes, G.F., Holmes, F.F., Latourette, H.B., Teta, M.J., et al. 1989.
Marriage and divorce after childhood and adolescent cancer. Jama 262:26932699.

28.

Langeveld, N.E., Ubbink, M.C., Last, B.F., Grootenhuis, M.A., Voute, P.A.,
and De Haan, R.J. 2003. Educational achievement, employment and living
situation in long-term young adult survivors of childhood cancer in the
Netherlands. Psychooncology 12:213-225.

29.

Meadows, A., McKee, L, Kazak, AE. 1989. Psychosocial Status of Young
Adult Survivors of Childhood Cancer: A Survey. Medical and Pediatric
Oncology 17:466-470.

30.

Pastore, G., Mosso, M.L., Magnani, C., Luzzatto, L., Bianchi, M., and
Terracini, B. 2001. Physical impairment and social life goals among adult
long-term survivors of childhood cancer: a population-based study from the
childhood cancer registry of Piedmont, Italy. Tumori 87:372-378.

31.

Rauck, A.M., Green, D.M., Yasui, Y., Mertens, A., and Robison, L.L. 1999.
Marriage in the survivors of childhood cancer: a preliminary description
from the Childhood Cancer Survivor Study. Med Pediatr Oncol 33:60-63.

32.

Janson, C., Termuhlen, A., Mertens, A., Whitton, J., Leisenring, W.,
Robison, L.L., Zeltzer, L., and Kadan-Lottick, N. Marriage and Divorce
Among Adult Survivors of Childhood Cancers: A Report from the
Childhood Cancer Survivor Study In progress.

33.

Nathan, P.C., Patel, S.K., Dilley, K., Goldsby, R., Harvey, J., Jacobsen, C.,
Kadan-Lottick, N., McKinley, K., Millham, A.K., Moore, I., et al. 2007.

65
Guidelines for identification of, advocacy for, and intervention in
neurocognitive problems in survivors of childhood cancer: a report from the
Children's Oncology Group. Arch Pediatr Adolesc Med 161:798-806.
34.

Brouwers, P., Riccardi, R., Poplack, D., and Fedio, P. 1984. Attentional
deficits in long-term survivors of childhood acute lymphoblastic leukemia
(ALL). J Clin Neuropsychol 6:325-336.

35.

Goff, J.R., Anderson, H.R., Jr., and Cooper, P.F. 1980. Distractibility and
memory deficits in long-term survivors of acute lymphoblastic leukemia. J
Dev Behav Pediatr 1:158-163.

36.

Gioia, G., Isquith, P., Guy, S., and Kenworthy, L. 2000. BRIEF: Behavior
Rating Inventory of Executive Function, Professional Manual. Lutz, FL:
Psychological Assessment Resources, Inc.

37.

Butler, R.W., Hill, J.M., Steinherz, P.G., Meyers, P.A., and Finlay, J.L. 1994.
Neuropsychologic effects of cranial irradiation, intrathecal methotrexate,
and systemic methotrexate in childhood cancer. J Clin Oncol 12:2621-2629.

38.

Packer, R.J., and Mehta, M. 2002. Neurocognitive sequelae of cancer
treatment. Neurology 59:8-10.

39.

Grill, J., Renaux, V.K., Bulteau, C., Viguier, D., Levy-Piebois, C., SainteRose, C., Dellatolas, G., Raquin, M.A., Jambaque, I., and Kalifa, C. 1999.
Long-term intellectual outcome in children with posterior fossa tumors
according to radiation doses and volumes. Int J Radiat Oncol Biol Phys
45:137-145.

40.

Hollen, P.J., and Hobbie, W.L. 1993. Risk taking and decision making of
adolescent long-term survivors of cancer. Oncol Nurs Forum 20:769-776.

41.

Levin Newby, W., Brown, R.T., Pawletko, T.M., Gold, S.H., and Whitt, J.K.
2000. Social skills and psychological adjustment of child and adolescent
cancer survivors. Psychooncology 9:113-126.

42.

Evans, S.E., and Radford, M. 1995. Current lifestyle of young adults treated
for cancer in childhood. Arch Dis Child 72:423-426.

43.

Armstrong FD, M.R. Acute lymphoblastic leukemia and brain tumors. In
Cognitive aspects of chronic illness in children R.B. (ed), editor. New York:
Guilford. 47-77.

44.

Dolgin, M.J., Somer, E., Buchvald, E., and Zaizov, R. 1999. Quality of life in
adult survivors of childhood cancer. Soc Work Health Care 28:31-43.

66
45.

Hays, D.M., Landsverk, J., Sallan, S.E., Hewett, K.D., Patenaude, A.F.,
Schoonover, D., Zilber, S.L., Ruccione, K., and Siegel, S.E. 1992.
Educational, occupational, and insurance status of childhood cancer
survivors in their fourth and fifth decades of life. J Clin Oncol 10:1397-1406.

46.

Bandura, A. 1977. Self-efficacy: toward a unifying theory of behavioral
change. Psychol Rev 84:191-215.

47.

Wheeler, V., and Ladd, G. 1982. Assessment of Children's Self-Efficacy for
Social Interactions with Peers. Developmental Psychology 18:795-805.

48.

Harter, S. 1982. The Perceived Competence Scale for Children. Child
Development 53:87-97.

49.

Ladd, G., and Price, J. 1986. Promoting Children's Cognitive and Social
Competence: The Relation between Parents' Perceptions of Task Difficulty
and Children's Perceived and Actual Competence. Child Development
57:446-460.

50.

Reynolds, C., and Kamphaus, R. 2004. BASC-2: Behavior ASsessment System
for Children, Second Edition. Circle Pines, MN: AGS Publishing.

51.

Doyle, A., Ostrander, R., Skare, S., Crosby, R.D., and August, G.J. 1997.
Convergent and criterion-related validity of the Behavior Assessment System
for Children-Parent Rating Scale. J Clin Child Psychol 26:276-284.

52.

Gioia, G.A., Isquith, P.K., Guy, S.C., and Kenworthy, L. 2000. Behavior
rating inventory of executive function. Child Neuropsychol 6:235-238.

53.

Varni, J.W., Seid, M., and Kurtin, P.S. 2001. PedsQL 4.0: reliability and
validity of the Pediatric Quality of Life Inventory version 4.0 generic core
scales in healthy and patient populations. Med Care 39:800-812.

54.

Landis, J.R., and Koch, G.G. 1977. The measurement of observer agreement
for categorical data. Biometrics 33:159-174.

55.

Theunissen, N.C., Vogels, T.G., Koopman, H.M., Verrips, G.H.,
Zwinderman, K.A., Verloove-Vanhorick, S.P., and Wit, J.M. 1998. The
proxy problem: child report versus parent report in health-related quality of
life research. Qual Life Res 7:387-397.

56.

Brown, R.T., Madan-Swain, A., and Lambert, R. 2003. Posttraumatic stress
symptoms in adolescent survivors of childhood cancer and their mothers. J
Trauma Stress 16:309-318.

67
57.

Best, M., Streisand, R., Catania, L., and Kazak, A.E. 2001. Parental distress
during pediatric leukemia and posttraumatic stress symptoms (PTSS) after
treatment ends. J Pediatr Psychol 26:299-307.

58.

Sloper, T., Larcombe, I.J., and Charlton, A. 1994. Psychosocial adjustment
of five-year survivors of childhood cancer. J Cancer Educ 9:163-169.

59.

Langeveld, N.E., Grootenhuis, M.A., Voute, P.A., de Haan, R.J., and van den
Bos, C. 2004. Quality of life, self-esteem and worries in young adult survivors
of childhood cancer. Psychooncology 13:867-881.

60.

Koocher GP & O’Malley, J.E., editor. 1981. The Damocles syndrome:
Psychologic consequences of surviving childhood cancer. New York:
McGraw-Hill.

61.

Kupst, M.J., and Schulman, J.L. 1988. Long-term coping with pediatric
leukemia: a six-year follow-up study. J Pediatr Psychol 13:7-22.

